Role of NOS-like proteins found in bacteria by Dupont, Andrea












presented to the University of Waterloo 
in fulfillment of the 
thesis requirement for the degree of 






Waterloo, Ontario, Canada, 2006 
 
 




I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, 
including any required final revisions, as accepted by my examiners. 







Nitric oxide (•NO) is a molecule with diverse biological effects involved in both 
signaling and defense mechanisms in mammalian systems.  The production of •NO is 
catalyzed from L-Arginine by a family of enzymes known as nitric oxide synthases (NOS).  
All mammalian isoforms contain an active site oxygenase domain and an electron-donating 
reductase domain joined by a calmodulin binding region.  Recently, prokaryotic homologues 
to the oxygenase domain of mammalian NOS enzymes have been identified.  Although 
several bacterial NOS (bNOS) enzymes have been characterized, their function is still 
unknown.  Possible roles for this enzyme could include: (i) intercellular signaling to 
coordinate cellular/infectious activity, (ii) regulation via •NO-mediated posttranslational 
modifications, or (iii) nitration of compounds in different biosynthetic pathways.  Efforts, 
contained in this thesis, to determine a probable role for this enzyme are two-fold: (i) via a 
search for possible interacting protein partners, and (ii) via a proteomic analysis of the effects 
of a knockout of the bNOS gene.   
Bacterial-NOS knockouts in Bacillus subtilis and Bacillus cereus have been created.  
2D-Differential in gel electrophoresis (DIGE) has been used to analyze the proteomic effects 
of the expression of this gene in B. subtilis.  Thus far 16 proteins which exhibited significant 
changes in expression, with a p value ≤ 0.05 and fold change ≥│2│, have been isolated and 
identified by peptide mass fingerprinting (PMF) in order to shed light on the relevance of this 
bacterial NOS homologue.  The proteins which have been identified thus far are involved in 
cellular metabolism, amino acid metabolism and nitrogen metabolism.  The identification of 
further proteins is required for a broader view of the impact of the expression of this gene on 
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Chapter 1: Introduction 
 Nitric oxide (•NO) is a molecule with diverse biological effects that has been shown 
to play significant roles in signaling and defense mechanisms in mammalian systems.  This 
free radical is biologically important due to its highly reactive nature and ability to readily 
permeate membranes (Snyder and Bredt, 1992).  Not only can •NO react with •NO receptors, 
it can also mutate DNA, inhibit DNA repair and synthesis, inhibit protein synthesis, and 
regulate protein activity via protein posttranslational modification of amino acid residues or 
metal centers (Bogdan, 2001). 
 The production of •NO is catalyzed by a family of enzymes known as Nitric Oxide 
Synthases (NOS).  Although NOS homologues have been shown to be prevalent across the 
genomes of eukaryotic organisms (Ghosh and Salerno, 2003), efforts thus far have focused 
on mammalian NOS enzymes (mNOS) due to their importance in both physiological and 
pathological processes.  Recently, it has been noted that many prokaryotic genomes contain 
NOS-like proteins (bNOS) which show significant sequence homology to the oxygenase 
domain of mNOS isozymes.  This is of particular interest due to the fact that mammalian 
systems produce •NO to defend the host against bacterial infection (Bogdan, 2001). 
 This thesis will first highlight some key aspects of mNOS isozymes and the current 
knowledge of prokaryotic NOS-like proteins.  Potential roles for these intriguing proteins 
will be suggested.  Studies to determine the physiological role of bNOS enzymes will then 
follow in later chapters.  
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1.1 Mammalian NOS 
1.1.1 NOS Isoforms 
 There are three isoforms of NOS found in mammalian systems: neuronal (nNOS), 
endothelial (eNOS), and inducible (iNOS).  Both eNOS and nNOS produce •NO that acts as a 
second messenger by activation of soluble guanylyl cyclase (sGC) in the cardiovascular and 
nervous system, respectively (Li and Poulos, 2005).  These two isoforms are collectively 
known as the cNOS enzymes because they are constitutively expressed and are regulated by 
intracellular levels of Ca2+.  The iNOS isoform produces cytotoxic levels of •NO in response 
to cytokine production.  It is active at basal intracellular levels of Ca2+ and is instead 
transcriptionally regulated.  
1.1.2 Domain Architecture 
 All NOS isoforms have similar domain architecture, consisting of both an active site 
oxygenase domain and an electron donor reductase domain joined by a calmodulin (CaM) 
binding region (Mungrue, Bredt et al., 2003).  Figure 1.1 shows a linear alignment of the 
three mammalian isoforms, highlighting binding domains for specific enzyme cofactors and 




Figure 1.1– Linear alignment of the three mammalian NOS isoforms.  
The catalytic oxygenase domain and reductase domain are represented showing the important binding domains, 
regulatory elements and localization factors (taken from Mungrue, et al., 2003).  PSD-95 discs large/ZO-1 
(PDZ) domain, myristoylation (Myr) and palmitoylation (Palm) sites, are all involved in cellular localization.  
Binding domains for the substrate L-Arginine (Arg) and the coenzymes Tetrahydrobiopterin (BH4), Heme, 
flavin mononucleotide (FMN), flavin-adenine dinucleotide (FAD), nicotinamide adenine dinucleotide 
phosphate (NADPH) are indicated.  The calmodulin binding domain (CaM) and the autoinhibitory (AI) 
regulatory element are also identified in this figure and described in the text.   
 
 The C-terminus loop is a 20-40 amino acid segment that is thought to interact with 
the reductase domain.  This interaction regulates the electron flow through the flavin (FAD 
and FMN) domains in iNOS and the electron transfer between the flavin and heme domains 
in the cNOS isoforms (Sagami, Sato et al., 2002).  The flow of electrons from the flavin 
mononucleotide (FMN) to the heme is controlled by an additional regulatory element in the 
FMN domain of the cNOS isoforms, and is known as the autoinhibitory (AI) element 
(Salerno, Harris et al., 1997).  The binding of CaM prevents the interaction of these 
regulatory elements with the reductase domain and alters the structure of NOS for efficient 
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electron transfer (Li and Poulos, 2005).  Once freed from the AI element, the FMN domain is 
believed to swing freely between the flavin-adenine dinucleotide (FAD) and the heme 
domains for efficient electron transfer (Garcin, Bruns et al., 2004).  In this state, the AI 
domain is accessible to proteolytic cleavage (Roman, Martasek et al., 2002).  Removal of the 
AI element results in tighter binding of CaM and possibly closer FMN to heme contacts 
leading to more efficient electron transfer (Li and Poulos, 2005).   
1.1.2 Crystal Structure Highlights 
 The structure of the catalytically important sites are highly conserved throughout the 
three isoforms.  Crystal structures obtained for the oxygenase domain indicate that all 
residues that are important for substrate and cofactor binding sites are highly conserved 
(Crane, Arvai et al., 1997; Crane, Arvai et al., 1998; Li and Poulos, 2005).  The substrate 
binding pocket is maintained except for the residues that interact with the substrate carboxyl 
group, which is aspartate in nNOS and iNOS and asparagine in eNOS.  However, this change 
has no apparent effect on substrate binding affinity.  The cofactor tetrahydrobiopterin (H4B) 
plays a key role in NOS catalysis and dimer formation.  This pterin molecule is sandwiched 
between tryptophan (Trp) and phenylalanine residues at the dimer interface of adjacent 
monomers (Li and Poulos, 2005) and is maintained in all three isoforms.   
The highly conserved nature of the active site constitutes a challenge for the design of 
NOS isoforms specific drug therapies.  However, other sites, such as the substrate access 
channel, can be targeted for isoform-selective inhibitors (Li and Poulos, 2005).  
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 A crystal structure for full-length mNOS has yet to be published due to difficulties in 
obtaining crystals; this could be due to flexibility in catalytically important regions as 
described above for the mobile elements such as the CaM binding region and the AI domain 
(Garcin, Bruns et al., 2004).  In attempts to build a structural model of the active protein, the 
known structures of proteolytic fragments have been combined.  It has been widely accepted 
for some time that the oxygenase domain exists as an active dimer (Andrew and Mayer, 
1999).  Mutational studies aimed at disrupting the dimer interface confirm this fact by 
showing a decrease in enzymatic activity (Li and Poulos, 2005).  The reductase domain was 
believed to exist as a monomer until Garcin et al. reported the crystal structure for a 
dimerized reductase domain in 2004. 
The current model of NOS from Garcin and coworkers (2004) is based on crystal 
structures obtained for isolated reductase domains aligned with previously obtained 
structures for oxygenase domains.  Garcin et al. have proposed the model shown in Figure 
1.2 based on knowledge that electrons flow through the reductase domain of one subunit to 
the oxygenase domain of the adjacent subunit (Siddhanta, Presta et al., 1998).   
Figure 1.2 illustrates the flow of electrons through the reductase domain to the 
oxygenase domain.  Not shown in this diagram is the proposed mobility of the FMN domain.  
The great distance (approximately 30 Å) between the FMN and the Heme domains illustrate 
the necessity for mobility of the FMN domain for efficient electron transfer.  Garcin and 
coworkers suggest that the FMN domain is mobile and swings from an electron accepting 
position to an electron donating position in close proximity to the FAD and heme domains, 
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Figure 1.2– Model of mammalian NOS dimer showing intermolecular electron transfer.   
Binding domains for the substrate L-Arginine (Arg) and the coenzymes Tetrahydrobiopterin (BH4), Heme, 
flavin mononucleotide (FMN), flavin-adenine dinucleotide (FAD), nicotinamide adenine dinucleotide 
phosphate (NADPH), calmodulin (CaM), are all indicated.  The electrons flow through the reductase of one 
subunit to the heme centre in the oxygenase domain of the adjacent subunit is illustrated by curved arrows 
(Adapted from Garcin et al., 2004). 
1.1.2 NOS Mechanism 
 All NOS isoforms catalyze the conversion of L-Arginine (L-Arg) to •NO and L-





Figure 1.3– Overall reaction for mammalian Nitric oxide synthase (NOS).   
•NO production from L-Arginine and NADPH catalyzed by NOS through the intermediate N-Hydroxy-L-
Arginine. 
 
The catalytic mechanism of NOS involves two successive mono-oxygenation reactions.  The 
first cycle involves the hydroxylation of the guanidino nitrogen of L-Arg to form the 
intermediate L-NOHA.  The second cycle involves the oxidation of the L-NOHA to L-Cit and 
•NO.   
 A catalytic model of NOS activity is illustrated in Figure 1.4.  The reductase domain 
provides the first reducing equivalent to the heme domain through the flavins, which are 
initially reduced via a hydride transfer from nicotinamide adenine dinucleotide phosphate 
(NADPH).  This is thought to be the slowest step during catalysis (Garcin, Bruns et al., 
2004).  The reduced heme binds O2 and is further reduced by a second electron either derived 
from H4B or from the reductase domain in the absence of H4B (Adak, Wang et al., 2000).  
Fast and efficient electron transfer is important at this step to prevent superoxide release.  
Superoxide is a highly reactive free radical which reacts with proteins, DNA, and lipids, 
causing damage which is referred to as oxidative stress.  The reduced heme binds O2 
enabling the hydroxylation of the substrate, L-Arg.  It is important to note that H4B is not 
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consumed during catalysis.  H4B is subsequently regenerated from an electron derived from 
the reductase domain, suspected to be mediated through a reduced heme site (Stuehr, Wei et 
al., 2005). 
  
Figure 1.4– Model for •NO synthesis catalyzed by NOS via two mono-oxygenation reactions. 
Details are given in text.  Figure taken from Stuehr et al., 2004. 
 
During the second catalytic cycle, the heme is again first reduced by the reductase domain, 
followed by binding of O2 and heme reduction by H4B.  The reduced heme is then able to 
oxidize the L-NOHA resulting in release of L-Cit and the formation of a ferrous heme-NO 
complex.  The H4B is regenerated in this case by a downstream reactive intermediate, most 
likely the heme-bound NOHA tetrahedral intermediate (Adak, Wang et al., 2000; Li and 
Poulos, 2005).  In the absence of H4B, the ferrous heme-NO complex builds up and oxidative 
products are released instead of •NO.   
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•NO has a high affinity for heme, and thus under normal conditions is slowly released 
from the heme-NO complex.  An unproductive side reaction, referred to as futile cycling, can 
occur in the presence of O2, yielding non-productive nitrogen oxide species such as NO2- and 
NO3-.  Figure 1.5 illustrates the kinetic constants that result in the distribution between the 
productive and futile cycle.    
 
Figure 1.5– Model for the dissociation of the Fe3+-NO complex during NOS catalysis. 
Both the productive cycle and the futile cycles of NOS catalysis are illustrated with the heme center shown as 
Fe.  The productive cycle results in the fast release of NO from the NO-Fe3+ complex.  A low kd of the Fe3+-NO 
complex results in futile cycling via reduction of the heme center to NO-Fe2+ and subsequent release of 
oxidative products of NO. Figure taken from Wang, et al., 2004. 
 
The differences between the O2 and NO binding affinities account for the differential rates of 
•NO production for different isoforms (Stuehr, Santolini et al., 2004).  It has been suggested 
that bNOS enzymes may kinetically favor futile cycling to limit the antimicrobial effects of 
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the productive cycle (Stuehr, Santolini et al., 2004; Wang, Wei et al., 2004; Li and Poulos, 
2005). 
1.2 Bacterial NOS 
Recently, several prokaryotic genomes have been shown to contain a genetic homologue to 
the oxygenase domain of mNOS enzymes.  Bacteria are known to produce •NO as an 
intermediate of denitrification; however, the enzymes involved are both structurally and 
mechanically distinct from bNOS (Bird, Ren et al., 2002).  The actual function of bNOS 
enzymes is still unknown, since the standard signaling and defense mechanisms mNOS 
enzymes would have no purpose in prokaryotic organisms.  Due to the cytotoxic effects of 
this molecule, bacteria control •NO concentrations at nanomolar levels by tight binding of 
this intermediate during nitrogen cycling (Bird, Ren et al., 2002).  This thesis will explore the 
prevalence of bNOS proteins and suggest possible roles for such a protein.  Efforts to 
elucidate this role will be discussed in chapter 3. 
1.2.1 Prevalence of bNOS in prokaryotic systems  
1.2.1.1 Oxygenase domain 
 The degree of homology between the oxygenase domain of mammalian NOS 
isoforms and putative bNOS enzymes is surprising.  Figure 1.6 shows a linear alignment of 
the oxygenase domain of the three mNOS isoforms with four bNOS proteins; Bacillus cereus 
(bcNOS), Bacillus subtilis (bsNOS), Staphylococcus aureus (saNOS), Deinococcus 
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radiodurans (deiNOS).  Based on alignments done to human iNOS oxygenase domain using 
the program ClustalW, these proteins show between 37-44% sequence identity and 56-64% 
sequence similarity (Altschul, Gish et al., 1990).   
The bNOS enzymes bsNOS, saNOS and deiNOS have previously been expressed, 
purified, and characterized.  The bcNOS protein has recently been expressed, purified, and 
characterized in our lab.  bcNOS is of interest due to its high degree of homology, 97% 
identical and 100% similar, to the equivalent bNOS protein found in Bacillus anthracis 
(baNOS) (Altschul, Gish et al., 1990).  Due to the high degree of homology between these 
two genomes, studies using B. cereus may provide insights into understanding this highly 
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Figure 1.6– Linear alignment of the oxygenase domain.  
Alignment of the three mNOSd to NOS-like protein found in Bacillus cereus NOS (bcNOS), Bacillus subtilis 
NOS (bsNOS), Staphylococcus aureus NOS (saNOS), Deinococcus radiodurans NOS (deiNOS) performed 
using ClustalW.  Degree of shading is indicative of sequence homology. 
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 Homology searches done with putative bacterial NOS sequences reveal an abundance 
of NOS-like proteins in bacterial genomes (Altschul, Gish et al., 1990).  Figure 1.7 shows a 
taxonomic tree illustrating the distribution of NOS-like proteins found in prokaryotic 
systems.  The distribution of bNOS is thus far limited to the gram-positive organisms and is 
particularly prevalent in the in the Bacillus genus.  
Bacteria – 38 
Firmicutes - 32 
 Bacillales - 31 
  Bacillaceae - 16 
       Bacillus anthracis - 1 
    Bacillus cereus (strain ATCC 10987) - 1 
   Bacillus cereus (strain ATCC 14579 / DSM 31) - 1 
   Bacillus cereus (strain ZK / E33L) - 1 
   Bacillus cereus G9241 - 1 
   Bacillus cereus subsp. cytotoxis NVH 391-98 - 1 
     Bacillus clausii (strain KSM-K16) - 1 
      Bacillus halodurans - 1 
      Bacillus licheniformis (strain DSM 13 / ATCC 14580) - 1 
       Bacillus sp. NRRL B-14911 - 1 
      Bacillus subtilis - 1 
     Bacillus thuringiensis subsp. konkukian - 1 
    Bacillus weihenstephanensis KBAB4 - 1 
   Exiguobacterium sibiricum 255-15 - 1 
     Geobacillus kaustophilus - 1 
   Oceanobacillus iheyensis - 1 
  Staphylococcus - 15 
   Staphylococcus aureus - 1 
   Staphylococcus aureus (strain COL) - 1 
   Staphylococcus aureus (strain MRSA252) - 1 
   Staphylococcus aureus (strain MSSA476) - 1 
   Staphylococcus aureus (strain MW2) - 1 
    Staphylococcus aureus (strain Mu50 / ATCC 700699) - 1 
   Staphylococcus aureus (strain N315) - 1 
     Staphylococcus aureus (strain NCTC 8325) - 1 
     Staphylococcus aureus (strain USA300) - 1 
   Staphylococcus aureus (strain bovine RF122) - 1 
   Staphylococcus aureus subsp. aureus JH1 - 1 
   Staphylococcus aureus subsp. aureus JH9 - 1 
   Staphylococcus epidermidis (strain ATCC 12228) - 1 
   Staphylococcus epidermidis (strain ATCC 35984 / RP62A) - 1 
   Staphylococcus haemolyticus (strain JCSC1435) - 1 
 Lactobacillales - 1 
   Lactobacillus plantarum - 1 
Actinobacteria - 5 
 Actinomycetales - 5 
   Streptomyces avermitilis - 2 
   Streptomyces acidiscabies - 1 
   Streptomyces scabies - 1 
   Streptomyces turgidiscabies - 1 
Deinococcus-Thermus - 1 
   Deinococcus radiodurans – 1 
 
Figure 1.7– Taxonmic tree of distribution of bNOS in prokaryotic systems. 
(Hulo, Bairoch et al., 2006) 
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A link has yet to be drawn between those bacteria that contain a bNOS gene and a 
specific phenotypic trait.  This list is by no means complete and will certainly increase with 
subsequent bacterial genomes being sequenced.  Perhaps with a fuller list, the link to a 
phenotypic trait will be more evident. 
1.2.1.2 Reductase Domain 
 Since bNOS proteins contain only the NOS oxygenase domain, a surrogate reductase 
domain would be required for catalytic activity.  Several putative reductase domains have 
been suggested for such a role and the specifics of these will be discussed in Chapter 2.  The 
number of potential electron-donating partners is very high.  Meanwhile, in order to 
characterize the activity of these enzymes, recombinantly expressed bNOS enzymes have 
been reconstituted with mNOS reductase domains.  The identity of this surrogate reductase 
domain would not only allow for a more accurate determination of the catalytic properties of 
bNOS enzymes but could also shed light on the possible role of these enzymes.  Attempts at 
the elucidation of possible surrogate reductase domains are described in Chapter 2. 
1.2.2 Crystal Structure 
 The structures of bNOS proteins, bsNOS, saNOS, and Geobacillus 
stearothermophilus NOS (gsNOS), have been solved by X-ray crystallography (Bird, Ren et 
al., 2002; Pant, Bilwes et al., 2002; Pant and Crane, 2006; Sudhamsu and Crane, 2006).  An 
additional structure has been suggested for deiNOS, based on threading algorithms (Adak, 
Bilwes et al., 2002).  The dimeric structures obtained for bNOS like enzymes are remarkably 
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similar to structures obtained for the oxygenase domain of mNOS.  The main difference 
between the bacterial and mammalian NOS structures is found along the dimer interface and 
at the N-terminus.  The N-terminal hook extension, which has been shown to be required for 
dimer formation and activity in mNOS isozymes, is missing in bNOS enzymes.  Deletions in 
the bNOS enzymes appear to be primarily surface-exposed loops in eukaryotic NOS 
structures, and do not alter the protein’s conformation (Pant, Bilwes et al., 2002).  Other 
residues thought to be important for dimerization in mNOS enzymes are also missing from 
bNOS proteins.  The conserved cysteine residues required for zinc binding and dimerization 
in mammalian systems (Mitchell, Erwin et al., 2005) are absent, and not required for 
dimerization in bNOS enzymes.   
Although the residues involved in the substrate and pterin binding sites are generally 
conserved between eukaryotic and prokaryotic NOS proteins, the absence of the N-terminal 
extension results in a more open structure and a wider substrate access channel (Bird, Ren et 
al., 2002).  Figure 1.8 shows a comparison of mouse iNOS and bsNOS.  The missing N-
terminal residues, highlighted in mauve, result in a more open structure for binding larger 
pterin molecules such as Tetrahydrofolate (THF).  This feature is important since some 
prokaryotes which contain bNOS enzymes are unable to produce H4B, but are able to 






Figure 1.8- Crystal structure comparison of bsNOS and mouse iNOS.   
The N-terminal hook extension which is missing in the bsNOS structure is highlighted in mauve.  The overall 
structure of bsNOS is more open at the dimer interface than mouse iNOS, allowing for binding of a larger pterin 
cofactor.  The pterin molecules are shown bound to the appropriate structure, THF in bsNOS and H4B in mouse 
iNOS (Pant, Bilwes et al., 2002). 
 
 Another conserved difference between eukaryotic and prokaryotic NOS is a valine to 
isoleucine switch found near the substrate binding pocket.  Wang and coworkers (2004) 
showed that this conserved residue switch causes a 10-20 fold decrease in •NO dissociation 
rate in bNOS enzymes.  They suggested that this residue switch may help to regulate •NO 
release in prokaryotic systems by decreasing the dissociation constant of •NO and thus 
increasing the proportion of futile cycling, as previously illustrated in Figure 1.5 (Wang, Wei 
et al., 2004).      
1.2.3 Characterization 
 Several bNOS proteins have been isolated and characterized.  NOS-like proteins from 
Nocardia (nocNOS), saNOS, deiNOS, bsNOS, baNOS, and gsNOS have all shown to 
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produce L-Cit and •NO from L-Arg.  Both nocNOS and saNOS were purified from crude cell 
extracts (Chen and Rosazza, 1995; Choi, Chang et al., 1997), and were shown to produce 
•NO (or NO2-, NO3-) in the presence of L-Arg or NOHA, NADPH and H4B without the 
requirement of a reductase domain.  Several bacterial NOS enzymes including baNOS, 
bsNOS, deiNOS, saNOS, Streptomyces turgidiscabies (stNOS), and gsNOS have been 
recombinantly expressed and purified.   These enzymes were shown to produce minimal 
levels of nitrite in the presence of either H2O2 or a rat nNOS reductase domain acting as 
surrogate electron donors (Adak, Aulak et al., 2002; Adak, Bilwes et al., 2002; Sudhamsu 
and Crane, 2006).  Significant •NO production by bNOS has not been shown in bacterial 
systems.  The relevance of •NO production using a mNOS reductase domain has yet to be 
shown.  The ability of this bNOS enzymes to produce •NO would more appropriately be 
demonstrated if either bNOS enzymes were shown to produce •NO in vivo or if a bacterial 
electron-dononating protein partner was found to interact with bNOS enzymes in vivo and 
provide the means to produce •NO. 
The deiNOS, bsNOS, baNOS, and gsNOS enzymes were further shown to have high 
affinity for the substrate L-Arg and the cofactor H4B (Midha, Mishra et al., 2005).  The 
deiNOS and bsNOS enzymes have both been shown to productively bind both H4B and THF 
(Adak, Aulak et al., 2002; Adak, Bilwes et al., 2002).   
1.2.4 Potential Roles 
 If these bNOS proteins are conclusively shown to produce •NO, it is intriguing to 
consider the possible roles for such proteins.  Recall that mNOS enzymes are involved in 
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signaling and defense mechanisms, neither of which would be probable functions for 
prokaryotic organisms.  Even more striking is the possibility of the catalytic product being 
cytotoxic to the organism.  Thus, if this protein produces •NO in vivo, this reaction would 
need to be tightly regulated or possibly coupled to another reaction. 
 Possible roles for bNOS proteins could include inter/intracellular signaling or 
involvement in biosynthetic pathways.  These roles could be manifested in microorganisms 
by •NO production resulting in •NO release for signaling purposes, protein posttranslational 
modifications, or production of nitrosylated products. 
1.2.4.1 Intercellular Signaling 
Although it has long been thought that unicellular organisms act independently of one 
another, competing for nutrients within a niche, recent discoveries suggest that bacteria are 
quite social and depend on chemical signals to communicate.  This regulative process, 
termed quorum-sensing, allows population based regulation of genetic competence, 
conjugative plasmid transfer, sporulation, cell differentiation, biofilm formation, virulence 
response, as well as production of antibiotics, antimicrobial peptides and toxins and 
bioluminescence (Kleerebezem and Quadri, 2001).   
Presently, there are two basic quorum-sensing models.  The first, found most 
commonly in gram-negative bacteria, is based on direct binding of the pheromone to the 
transcriptional factor to control this regulative process (Waters and Bassler, 2005).  The 
second, found most often in gram-positive bacteria, is based on the pheromone binding to a 
receptor involved in a two-component phosphorelay signal transduction system that results in 
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gene regulation (Strume, Kleerebezem et al., 2002).  Both processes allow the cell to respond 
to environmental stimuli in a concentration dependent manner.   
Although the current model for quorum-sensing is limited to larger molecule 
pheromones such as acylhomoserine lactones and small peptides, perhaps small molecules 
such as •NO could also contribute to quorum-sensing.  Akin to the two-component 
phosphorelay signal transduction system found in quorum-sensing gram-positive bacteria, 
some bacterial systems contain a specific •NO receptor found in an operon that encode genes 
for a two-component, histidine kinase, signal transducing system.  These receptors are 
prokaryotic homologues to sGC and have been found in Clostridium botulinum (Nioche, 
Berka et al., 2004), Vibrio cholerae (Karow, Pan et al., 2004), and Thermoanaerobacter 
tengcongensis (Karow, Pan et al., 2004).  The sensors of •NO (SONO) have been expressed 
and characterized in vitro and were shown to have extremely high affinity for •NO (Nioche, 
Berka et al., 2004).  It has been suggested that this sensor could aid the bacteria in avoiding 
this cytotoxic material by inducing chemotaxis.  Although the signal transducing potential of 
this sensor has not been proven, it was suggested from amino acid sequence comparisons to 
mammalian sGC homologues.  The possible chemotaxis role of this sensor in the avoidance 
of this toxic substance by bacteria was also suggested based on the ability of mammalian 
sGC to confer a chemoattractive response to dendrites and axons (Nioche, Berka et al., 
2004).   
The possibility of SONO proteins contributing to the virulence has been suggested 
due to evidence of transcriptional down regulation of this gene in V. cholerae cells shed by 
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infected individuals.  This evidence suggests that the SONO may be important for bacterial 
virulence within the host. 
1.2.4.2 Intracellular Signaling 
 Another possible function for bNOS proteins found in bacteria is the involvement in 
intracellular signaling.  The nitration of proteins has been shown to significantly alter protein 
conformation and function.  In mammalian systems, the nitration of aromatic protein residues 
has been implicated in neurodegenerative diseases, atherosclerosis, infections, inflammation, 
and cancer (Buddha, Tao et al., 2004).  It is still unclear whether the increased formation of 
nitrated species is a causal agent or the result of the pathogenic onset of these diseased states 
(Schopfer, Baker et al., 2003).  Although most studies on protein nitration have focused on 
diseased states, there is increasing evidence suggesting that •NO-mediated posttranslational 
modification (PTM) is involved in cellular signaling.  It has been suggested that if this highly 
regulated process were altered that it could result in disease.   
 •NO-mediated protein nitration can occur via NO-heme complex formation, the S-
nitrosylation of cysteine (Cys) residues, or the C-nitration of tyrosine (Tyr) and Trp residues 
(Ischiropoulos, 2003).  These PTMs can mark proteins for degradation, regulate protein 
function, or contribute to amino acid metabolism.  The following criteria have been 
suggested by Koeck et al. (2005) to be required for •NO-mediated PTMs to be considered 
physiologically relevant to signaling: (i) the modification should be specific, (ii) the 
modification should be reversible, (iii) the modification should occur on a physiologically 
relevant time scale, and (iv) should alter the activity of the target (Green, Wagner et al., 
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1982; Koeck, Stuehr et al., 2005).  •NO-mediated PTM of metal centers, S-nitrosylation of 
Cys residues, and C-nitration of Tyr have shown to meet the criteria required for signaling 
(Green, Wagner et al., 1982; Schopfer, Baker et al., 2003; Koeck, Stuehr et al., 2005).  
Although very little work has been done on Trp nitration, it has been suggested to have a 
similar mechanism and physiological relevance as Tyr nitration (Yumakura and Ikeda, 2006).   
PTMs involving •NO can either be a result of •NO reacting directly with the target or 
via a secondary reaction involving a protein residue and a product of •NO oxidation.  •NO can 
react with metal centers or reduced thiols to produce nitrosylated proteins.  Equations 1 and 2 
illustrate the formation of nitrotyrosine using oxidative products of •NO.   
Tyr + •OH, •CO3- or •NO2 → Tyr• + OH-, CO32-or NO2- (1) 
Tyr• + •NO2 → O2N-Tyr  (2) 
•NO oxidative products, •NO2, ONOO-, and N2O3, are more reactive and toxic than •NO, and 
can mediate S-nitrosylation (Ravi, Brennan et al., 2004)  and C-nitration (Radi, 2004). There 
are several possible mechanisms by which proteins can react with reactive nitrogen species 
(RNS) and become nitrated.  The predominant species implicated in mediation of protein 
nitration are •NO2 and the carbonate radical (•CO3-) (Radi, 2004).  Tyr nitration depends on 
the concomitant production of •NO2 and Tyr radicals.  As illustrated in the above equations, 
the Tyr radical can be generated from several species. The production of peroxynitrite and 
the Tyr radical result in protein nitration.   
Some examples of enzymes involved in •NO-mediated PTMs:  Heme modification in 
sGC (Ignarro, Degnan et al., 1982), denitrase in mitochondria (Aulak, Koeck et al., 2004), S-
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nitrosylation of eNOS (Ravi, Brennan et al., 2004), iNOS (Mitchell, Erwin et al., 2005) and 
nNOS (Jaffrey, Erdjument-Bromage et al., 2001), C-nitration of Trp in Mn superoxide 
dismutase (MacMillan-Crow, Crow et al., 1996).    
NO modification can occur through a variety of mechanisms but have all shown to meet the 
criteria required for signaling pathways. 
Work on •NO-mediated PTM in bacteria has focused on the effect of nitrosative stress 
of a host on bacterial systems (Rhee, Erdjument-Bromage et al., 2005).  Further studies are 
required to determine if •NO-mediated PTM occur in bacterial cells under normal conditions.  
Future studies should address the possibility of •NO-mediated PTMs playing a role in 
signaling mechanisms in bacterial systems.   
1.2.4.3 Biosynthetic Pathways 
 Another alternative for a physiological role of bNOS proteins is involvement in 
biosynthetic pathways.  Coupling of the production of •NO to a biosynthetic reaction would 
allow the bacteria to direct reactivity and limit the toxicity of this product.  The bNOS 
protein found in S. turgidiscabies (stNOS) was shown to be involved in the nitration of a 
dipeptide phytotoxin required for plant pathogenicity (Kers, Wach et al., 2004).  Kers et al. 
(2004) suggested that stNOS is responsible for the nitration of the 4-nitrotryptophanyl moiety 
of the phytotoxin thaxtomin.  A knockout of this gene resulted in the bacteria lacking the 
ability to produce the phytotoxin, thaxtomin.  Similarly, the addition of known L-Arg-based 
NOS inhibitors resulted in decreased production of the phytotoxin.  Subsequently, Buddha et 
al. (2004) suggested that a tryptophanyl tRNA synthetase from D.radiodurans (deiTrpRS II) 
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interacts with deiNOS.  Buddha et al. (2004) showed that TrpRS II increases the solubility, 
substrate binding and stimulates deiNOS activity (Buddha, Keery et al., 2004).  Since D. 
radiodurans possesses another tryptophanyl tRNA synthetase (TrpRS I) with higher charging 
activity and with greater sequence homology to TrpRSs found in organisms that only contain 
one TrpRS, it was suggested that the TrpRS II is auxiliary to the protein synthesis machinery 
and possibly involved in production of biosynthetic products.  Further investigation of the 
deiNOS and deiTrpRS II complex showed that it was not only able to catalyze the production 
of •NO but also the regioselective nitration of tryptophan at the 4-position.  In this system, 
Trp was shown to stimulate nitrite production, while the Trp nitration reaction was inhibited 
by H4B (Buddha, Tao et al., 2004).  It was suggested that Trp may occupy the same site as 
and substitute for H4B as an electron donor in order to stimulate the production of •NO from 
L-Arg (Buddha, Tao et al., 2004).  It also follows that H4B would act as a competitive 
inhibitor for Trp in the nitration reaction.  Thus, coupling the nitration of an amino acid to a 
bNOS protein would limit the potential toxic effects of the •NO product.   
1.3 Overview of the Thesis 
Although many roles have been suggested for this intriguing enzyme, there has yet to 
be a consistent trend found between the existence of this enzyme and any specific 
physiological or pathological trait.  A trend of coexistence between bNOS and SONOs, 
trpRS II, or protein nitration has not been conclusively shown.  This work endeavors to shine 
light on the potential role of bNOS.   
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Chapter 2 shows the attempts to isolate possible electron-donating protein partners for 
bNOS enzymes.  Although it is evident that bNOS requires a physiological electron donating 
partner, none have been identified.  Methods used here to probe the interactions between 
bcNOS and any interacting protein partners include: (i) attempts at isolation of intact protein 
complexes from native sources and (ii) using previously purified bNOS as bait to fish-out 
any interacting partners from cell lysate solutions.  Determining the identity of electron 
donating partners for bNOS could shed light into the role of this intriguing enzyme.   
Chapter 3 is a proteomic view of the change in protein expression due to the knockout 
of the bNOS gene in B. subtilis.  This chapter outlines the methods used for generation of 
bNOS knockouts in B. subtilis and B. cereus.  The introduction of DIGE technology into our 
lab and the optimization of sample specific parameters are described.  A detailed summary of 
the procedures for 2D-DIGE comparison of the knockout and wild type strains is also 
provided.  The change in protein expression due to the bsNOS knockout is discussed, with 




Chapter 2: Attempts to identify electron donating partners 
for bNOS 
2.1 Introduction 
One of the remaining enigmas in the bacterial NOS (bNOS) realm is to determine the 
physiological electron donor for this system.  According to the mNOS mechanism, electrons 
must be transferred to the oxygenase domain in order for catalysis to occur.  It has been 
shown that recombinantly expressed rat nNOS and human iNOS reductase domains are able 
to transfer electrons to bNOS enzymes eliciting minimal •NO production (Adak, Aulak et al., 
2002; Adak, Bilwes et al., 2002; Buddha, Tao et al., 2004).  Although this is an interesting 
observation, the physiological relevance is quite limited.  The most we can infer from this 
observation is that bNOS enzymes are able to accept electrons from an electron donating 
partner.  The determination of a probable electron donor to this enzyme is key to 
understanding the role and possibly regulation of NOS-like enzymes found in prokaryotic 
systems.   
2.1.1 Possible bNOS Electron Donating Partners 
Several proteins have been suggested as possible electron donors for bNOSs, 
including sulfite reductase flavoproteins (SiR-FP), cytochrome P450 BM-3 (P450 BM-3) and 
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Flavodoxins.  These potential surrogates have been suggested for this role based on 
homology to the mNOS reductase domain and their coexistence with bNOS in bacterial 
systems.  Another possible interacting partner for bNOS could be a TrpRS II.  As mentioned 
in 1.2.4.3, this interaction was suggested after ∆stNOS was shown to inhibit the production 
of a nitrated dipeptide required for plant pathogenicity (Kers, Wach et al., 2004).  The 
coexistence of these putative electron donors with bNOS is summarized in Table 2.1. 
Table 2.1– Summary of coexistence of putative electron donating partners for bacterial NOS in selected 
bacterial species.  




like TrpRS II 
B. subtilis + + + + - 
B. halodurans + - - + - 
O. iheyensis + - + + - 
S. aureus + - - + - 
S. epidermidis + - - + - 
B. anthracis - + - + - 
B. cereus - + - + - 
D. radiodurans - - - + + 
*All organisms contained in this table encode a bNOS gene.  The coexistence of bacterial NOS with these 
putative electron donating partners is indicated by a ‘+’. 
(Zemojtel, Wade et al., 2003; Buddha and Crane, 2005; Hulo, Bairoch et al., 2006) 
2.1.1.1 Sulfite Reductase 
Sulfite reductase is a soluble oligomeric protein made up of two types of subunits in 
α8β4 stoichiometry.  The α subunit is a FAD-FMN-containing flavoprotein (SiR-FP) and the 
β subunit is a siroheme and an Fe4S4 cluster (Murataliev, Feyereisen et al., 2004).  Analogous 
to mNOS reductase, the SiR-FP transfers six electrons from 3 molecules of NADPH to the 
active site.  The coexistence of SiR-FP and bNOS was noted by Zemojtel et al. in 2003.  As 
illustrated in Table 2.1, SiR-FP is found in many, but not all, bacteria that code for bNOS.  A 
solution structure of a bacterial flavoprotein moiety of a sulfite reductase found in E. coli has 
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been obtained and was found to be homologuous in structure to cytochrome-P450 reductase 
and nitric oxide synthase reductase domain (Sibille, Blackledge et al., 2005).  Although the 
transfer of electrons from SiR-FP to cytochrome c and to a cytochrome-P450 enzyme have 
been demonstrated (Sibille, Blackledge et al., 2005), there have been no reported attempts to 
transfer electrons to NOS enzymes.   
2.1.1.2 Cytochrome P450 BM-3   
Cytochrome P450 BM-3 has analogous domain architecture to mNOS enzymes and 
thus has also been suggested as candidates for surrogate electron donors for bNOS enzymes 
(Zemojtel, Wade et al., 2003).  Similar to mNOS enzymes, the reductase domain is 
comprised of NADPH, FAD, and FMN binding domains; however, unlike mNOS, P450 BM-
3 catalyzes fatty acid hydroxylation (Gustafsson, Roitel et al., 2004).  There is no evidence of 
interaction of P450 enzymes with bNOS enzymes.  However, the ability of Cytochrome P450 
reductase to donate electrons to P450 BM-3 suggests the possibility of interaction with other 
analogous enzymes (Sibille, Blackledge et al., 2005).  The coexistence of P450-BM3 
enzymes in bacterial systems with bNOS, similar to other suggested electron-donating 
partners, does not show a consistent trend.   
2.1.1.3 Flavodoxin  
Another possibility for a surrogate electron donor for bNOS enzymes are short chain 
flavodoxins (Murataliev, Feyereisen et al., 2004).   Flavodoxins bind one molecule of FMN 
and act as an electron transfer protein in many electron transfer systems (Hulo, Bairoch et al., 
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2006).  In 2004, Lawson et al. cloned, overexpressed, and purified two B. subtilis flavodoxin 
proteins, ykuN and ykuP, in E. coli.  They showed that ykuN and ykuP both bound FMN and 
supported lipid hydroxylation catalyzed by a cytochrome-P450 enzyme.  However, no 
interaction with NOS was reported (Lawson, Wachenfeldt et al., 2004).     
Flavodoxin-like proteins are similar in domain architecture to flavodoxin proteins but 
have a more divergent sequence (Hulo, Bairoch et al., 2006).  Flavodoxin-like proteins are 
found to coexist in all the bNOS containing organisms listed in Table 2.1, and they might 
possibly function as electron donating partners for bNOS enzymes. 
2.1.1.4 Tryptophanyl-tRNA synthetase II  
Tryptophanyl-tRNA synthetase II is an aminoacyl-tRNA synthetase (AARSs) that is 
able to charge tRNA synthetase with nitro-tryptophan (Buddha and Crane, 2005).  Generally 
AARSs function to attach one of the standard 20 amino acids to tRNAs with the appropriate 
anticodon.  Most organisms only code for one AARS per amino acid, presumably to protect 
against the proliferation of mutations that would result in coupling inappropriate analogues.  
D. radiodurans contains two TrpRS enzymes.  The most divergent of the two, TrpRS II, was 
shown to interact with deiNOS (Buddha and Crane, 2005).  Buddha, Keery, et al. (2004) 
coexpressed deiTrpRS II and deiNOS in E. coli and showed that the use of copurification 
techniques significantly enhances the solubility of deiNOS (Buddha, Keery et al., 2004).  
Dimeric deiNOS was shown to bind dimeric deiTrpRS II in a 1:1 ratio, thereby increasing its 
affinity for the substrate L-Arg.  Buddha, Tao, et al. (2004) showed that this interaction was 
able to stimulate the regioselective nitration of Trp (Buddha, Tao et al., 2004).  The addition 
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of ADP was shown to stimulate production of 4-nitro-Trp, whereas the addition of H4B 
inhibits the nitration reaction and promotes the production of •NO.  Although TrpRS II are 
found in many bacteria, the specific residues suggested by Buddha and Crane in 2005 to be 
required for Trp modification are not found in any other Trp RS II which coexist with bNOS.  
The authors suggested that specific mutations in the TrpRS II active site are required to 
reorient the substrate to allow for the nitration reaction.   
2.1.2 Possible Docking Position Electron Donor for bNOS 
Regardless of which protein proves to interact with bNOS, ultimately the protein 
must donate electrons to the active site of bNOS enzymes.  A probable docking position has 
been suggested for these potential surrogate electron donors (Bird, Ren et al., 2002).  Three 
residues on the exposed heme edge that are conserved across bNOS sequences have been 
suggested as a probable site of interaction for an electron donating partner.  The following 
figure shows the dimeric structure of saNOS with the conserved residues along the exposed 




Figure 2.1- Crystal structure of Staphylococcus aureus NOS. 
The possible docking site for bNOS electron donating partner is highlighted.  The three residues that sit at the 
proposed docking site along the exposed heme edge are highlighted in turquoise and detailed in the text (Bird, 
Ren et al., 2002). 
2.1.3 Approach 
All of these candidate proteins have yet to be shown to interact with bNOS under 
native conditions in vivo.  It does not take long to realize many possible candidates for the 
role of electron donor exist within bacterial systems.  Two experimental approaches were 
tried to identify potential electron donating protein partners for bNOS in B. cereus: (i) Isolate 
intact bNOS protein complexes from native sources using conventional chromatography 
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methods or (ii) Fish-out the electron donor using affinity-tagged recombinantly expressed 
bNOS protein as a bait protein. 
The three chromatographic methods that have been previously used to isolate bNOS 
from native sources include (i) MonoQ column followed by Superose 12R (Choi, Oh et al., 
2000), (ii) MonoQ column followed by 2’5’ADP-agarose and then a Superdex 200HR 
column (Hong, Kim et al., 2003), and (iii) 2’5’ADP-agarose column followed by 
hydroxylapatite chromatography (Chen and Rosazza, 1995).  These methods were used in the 
current studies.  Two methods were used in our attempts to isolate intact bNOS-electron 
donor protein complexes: (i) MonoQ column followed by Superdex 300 column and (ii) 
2’5’-ADP-sepharose column followed by an L-Arg sepharose column.   
Alternatively, previously purified bcNOS was bound to different metal-chelating 
chromatography columns and used as bait in efforts to fish-out interacting proteins from the 
bacterial cell lysate.  Three different metal-chelating resins were used to probe these potential 
interactions: (i) Ni2+-chelating resin, (ii) Co2+-chelating resin, and (iii) Co2+-chelating 
magnetic resin.   
Nickel-based metal-chelating chromatography tends to be the most common form of 
metal-chelating chromatography due to its high affinity to His-tags.  Higher affinity 
properties allows for a more specific isolation of a target protein, which is a desirable trait 
when isolating recombinantly expressed His-tagged proteins.  For our purposes, higher 
affinity for the bait protein could allow for elution of potentially interacting partners prior to 
the elution of the bait protein.   
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Cobalt-based metal-chelating chromatography allows for purification of His-tagged 
proteins using less stringent elution conditions.  This is a desirable feature for pull-down 
experiments as it allows the elution of both the bait protein and potential interacting partners 
simultaneously.  The metallic resin is a spherical and monosized resin, with defined and 
highly controllable physical and chemical characteristics allowing for highly reproducible 
results. 
2.2 Procedures 
2.2.1 Strain and Growth Conditions 
The Bacillus cereus strain ATCC 10987 and the bcNOS enzyme cloned from this 
strain were used for all the following protocols.  The bcNOS gene from ATCC 10987 was 
cloned into pET28a, expressed as a His-tagged fusion protein and purified by Ni2+-chelating 
chromatography.  Cells were grown in 2XSG media (16 g Difco Bacto Nutrient Broth, 2 g 
KCl, 0.5 g MgSO4·7 H2O, pH to 7.0 with 1 M NaOH, autoclaved, cooled to 55◦C, then 1 mM 
CaCl2, 0.1 mM MnCl2·H2O, 1 uM FeSO4 were added).  One liter cultures were grown in 4 L 
flasks containing 2XSG media with and without the addition of 0.125 % methanol.  Cultures 
were inoculated from a saturated overnight culture with a 1% inoculum and were grown at 
30ºC for 18-48 hours, as indicated.  Cells were harvested at 8,000xg at 4◦C for 10 min.  Cells 
were stored at -80◦C until further processing.   
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2.2.2 Cell Disruption 
Cell lysate was prepared by resuspending the frozen cell pellet of 2-3L of B. cereus 
liquid culture in approximately 40 mL of the appropriate buffer specified for each 
chromatographic technique.  The cell were disrupted by homogenization using Emulsififlex-
C5 (Avestin) and centrifuged for 20,000xg for 30 min at 4°C.  
2.2.3 MonoQ/Sephacryl 300 Chromatography 
Approximately 40 mL of cell lysate in 40 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM 
DTT was loaded onto a MonoQ column (Pharmacia) equilibrated with Buffer A (40 mM 
Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM DTT, 2 µM H4B, 2 µM FAD, 2 µM FMN).  The 
column was washed with 5 column volumes of Buffer A and the protein was eluted with a 
linear gradient (0-0.75 M NaCl) in 10 column volumes.  The column was then washed with 2 
column volumes of Buffer B (0.75 M NaCl in Buffer A), 5 column volumes of H2O and 5 
column volumes of 20 % EtOH.  The protein peak that was eluted between 0.2-0.5 M NaCl 
was pooled, concentrated to ~1 mL and dialyzed into Buffer C (40 mM Tris-HCl, pH 7.5, 5 
% glycerol, 1 mM DTT, 250 mM NaCl) before loading onto a Sephacryl 300 column 
(Pharmacia).  The 24 mL column was eluted with 4 column volumes of Buffer C and then 
eluted with 4 column volumes Buffer C.  The column was washed with 8 column volumes of 




Both the ADP- and L-Arg-sepharose columns (GE Healthcare) were regenerated 3 
times using alternating high pH buffer (0.1 M Tris-HCl, 0.5 M NaCl, pH 8.5) and low pH 
buffer (0.1 M Sodium acetate, 0.5 M NaCl, pH 4.5) regeneration buffers and then 
equilibrated with 5 column volumes of ADP wash buffer (10 mM Tris-HCl, 1 mM EDTA, 1 
mM DTT, 2 µM H4B, pH 7.5).  Approximately 40 mL of cell lysate in ADP wash buffer was 
incubated with the resin with slow rotation for 1 hr at 4ºC and then packed into the column.  
The column was washed with 5 column volumes ADP wash buffer, 5 column volumes ADP 
salt wash buffer (10 mM Tris-HCl, 1 mM EDTA, 1 mM DTT, 2 µM H4B, 500 mM NaCl, pH 
7.5) and eluted in 20 mL with 10 mM 2’AMP and 500 mM NaCl in ADP wash buffer.  The 
eluate was concentrated, dialyzed into ADP wash buffer and loaded onto L-Arg sepharose 
resin by rotating in a centrifuge tube for 1 hr at 4ºC before transferring to a column.  The 
column was washed with 5 column volumes wash buffer and the protein was eluted in 20 mL 
wash buffer containing 1 M L-Arg.  The eluted fraction was concentrated 20 fold before 
analysis. 
2.2.5 Metal-Chelating Chromatography 
12.5 mg of previously purified His-tagged protein was dialyzed into Wash buffer (40 
mM Tris-HCl, 10 % glycerol, 1 mM L-Arg, 250 mM NaCl).  The bait protein was loaded 
onto the 20 mL NTA-Ni2+ agarose column (Novagen) by gravity and washed with 5 column 
volumes of wash buffer.  Approximately 40 mL of cell lysate in wash buffer containing 0.55 
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mg/mL Lysozyme (Roche) and 0.1 mg/mL DNase I (Roche) was loaded onto the column 
with the bound bait protein by slowly rotating the mixture in a centrifuge bottle for 1 hr at 
4ºC.  The column was washed with 5 column volumes of wash buffer, and subsequently with 
wash buffer containing 0.5, 50, 100, 200 mM imidazole, successively.     
2.2.6 ProFound™ Pull-Down PolyHis Protein:Protein Interaction Kit  
Immobilized Co2+-chelate resin was equilibrated using 1:1 ProFound™(PIERCE 
Biotechnology) wash solution of TBS:ProFound™ Lysis Buffer containing 40mM imidazole 
and 75 mM NaCl and 1% proprietary nonionic detergent.  650 µg of bait protein was diluted 
to 800 µL and then loaded onto the 50 μL column bed by slowly rotating the mixture for 30 
min at 4ºC.  The resin was washed 5 times with 800 µL wash buffer.  The cell lysate of a 1 L 
culture in 15 mL of ProFound™ wash solution was then loaded by rotating the mixture in a 
centrifuge tube for 1 hr at 4ºC.  The column was washed 5 times with 800 µL ProFound™ 
wash buffer before successive elutions with 100, 250, 500 mM NaCl in ProFound™ wash 
solution.  The final elution was preformed with 500 mM NaCl with 290 mM imidazole in 
ProFound™ wash solution as recommended by the manufacturer.  
2.2.7 Magnetic Resin 
Approximately 2 mg (50 μL) of immobilized Co2+-chelate resin from DYNAL® 
Biotech was equilibrated with 3 volumes of 100 μL of Talon™ Wash Buffer (50 mM sodium 
phosphate, pH 8.0, 300 mM NaCl, 0.01 % Tween-20) by separation of the resin with the use 
of a magnet.  100 μg of the bait protein was diluted to 700 μL with Talon™ wash buffer and 
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then loaded onto the magnetic resin by slowly rotating the mixture for 30 min.  The resin was 
washed 3 times with 700 μL Talon™ wash buffer and then 15 mL of the cell lysate was 
loaded by rotating the mixture in a centrifuge tube for 1 hr at 4ºC.  The resin was then 
washed 3 times with 700 μL of Talon™ wash buffer.  Fractions were eluted successively in 
100 µL of 500 mM NaCl and 150 mM Imidazole in Talon™ wash buffer.   
2.2.8 Protein Detection 
A series of 10 % SDS-PAGE gels were run on eluted fractions to determine the 
distribution of proteins within the samples. Approximately 20 μg of protein was loaded for 
each sample in separate lanes.  Gels were stained with Coomassie R-250.   
Western blots were performed by transferring proteins onto PVDF membranes 
overnight in a BIO-RAD electrophoretic transfer cell at 10 V at 4ºC.  The primary antibody 
(1ºAb) obtained from Transduction Laboratories was raised to a 21 kDa fragment 
corresponding to the C-terminal NADPH binding domain (residues 961-1144) of mouse 
iNOS.  Membranes were blocked with 1 % BSA in TBS-T for 2 hrs.  The membranes were 
incubated in a 1:5,000 solution of 1ºAb (Anti-iNOS Rabbit pAb) for 1 hr.  The membranes 
were washed 3 times in TSB-T before incubating in a 1:10,000 solution of secondary 
antibody (2ºAb) Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugate for 1 hr.  The 
membranes were washed 3 times in TBS-T and then blotted dry.  ECL detection solution (2 
mL solution A & 50 µL solution B) was poured over the surface of the membranes, wrapped 
in plastic wrap and incubated at room temperature for 5 min before visualizing.  
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Chemiluminescence was detected for 15-60 min using the Alpha innotech Flurochem 8000 
Chemiluminescence and visible imaging system. 
2.2.9 Determination of Nitric Oxide Production 
Production of nitric oxide in fractions was determined using the Griess Assay (Griess, 
1864; Ignarro, Buga et al., 1987) modified for use in a microtiter plate reader.  20 µL of 
purification samples were incubated at 37ºC for 25 min in the presence of 50 µM H4B, 1 mM 
L-Arg, or 20 μM NOHA, 20 μM CaM, 200 μM Ca2Cl2, 10 μM FAD, 10 μM FMN, 200 μM 
DTT, as indicated.  100 µL Griess reagents were added directly to the sample mixture.  The 
Griess reagents comprise a 1:1 ratio of freshly prepared 0.1 % naphthylethylenediamine 
(N5889, Sigma-Aldrich Canada Ltd., Oakville, ON) in MQ water and freshly prepared 1 % 
sulphanilamide (S9251, Sigma-Aldrich Canada Ltd., Oakville, ON) in 5 % phosphoric acid 
(Fisher Scientific, Nepean, ON).  Reaction mixture was allowed to react for 10 min at 25ºC 
before reading at 540 and 630 nm using a SPECTRAmax PLUS 384.  A standard curve was 
generated using 0-20 μM sodium nitrite. 
2.3 Results and Discussion 
2.3.1 Bacterial NOS Expression 
It was previously reported that bNOS expression can be induced by applying stress to 
the culture either by addition of methanol or by starvation (Choi, Seo et al., 1998).  However, 
expression tests, determined by β-gal activity, revealed that the bcNOS gene was expressed 
 
 38
late in exponential phase (see section 3.3.1.2) and that the presence of methanol did not 
significantly influence its expression.  Therefore, cells were grown in media without 
methanol and harvested according to bcNOS expression. 
2.3.2 Attempts at Isolation of Intact bNOS Protein Complex 
The anion exchange/size exclusion conditions were modeled after studies used to 
purify NOS from Salmonella typhimurium (Choi, Oh et al., 2000).  There studies 
characterized the elution of bNOS using qualitative NO analysis.  In the partially purified 
sample, a protein of 93 kDa was identified using an antibody raised against the C-terminus of 
iNOS (NADPH binding domain) (Choi, Oh et al., 2000).  Application of the same 
chromatographic purification scheme to a B. cereus lysate yielded protein bands of 30, 32, 
42, 60, & 66 kDa identified by Coomasie staining.  Although these fractions lacked the 
characteristic heme colour for NOS proteins, the 42 kDa protein could possibly be bcNOS 
and the other proteins are potential interacting partners.  The lack of characteristic heme 
colour for the eluted fractions could be a result of the protein releasing its heme during the 
purification process.  The other proteins may not necessarily interact with this 42 kDa 
protein, they could merely elute in the same fraction because they have similar binding 
properties for these columns.  These methods are not specific and yield many potential 
interacting proteins.  With no way of differentiating true interacting proteins, other methods 




Figure 2.2 – Fractionation of B. cereus lysate using MonoQ (A) and Sephacryl 300 (B) columns.  
 MonoQ gel (A) lane 1 unfractionated cell lysate, lanes 2-4, 7-10 eluted fractions, lane 5 low molecular weight 
marker, lane 6 purified bcNOS.  Sephacryl 300 gel (B) lane 1 MonoQ flowthrough, lane 2-4, 7-10 eluted 
fractions, lane 5 low molecular weight marker, lane 6 purified bcNOS.  Gel stained with Coomasie R-250. 
 
The ADP/L-Arg sepharose column conditions were modeled after the conditions used 
to purify NOS from S. aureus and Nocardia, in conjunction with the binding properties 
attributed to the bNOS enzymes.  In this system, the first column should bind NADPH-
binding proteins and the second column should bind proteins with an L-Arg binding pocket.  
Previous work isolating saNOS from native sources showed NOS activity using both a NO 
Analyzer (Model 7020, Antek Instruments) as previously described by Choi et al. in 2000 
and radioactive L-[3H]Arginine assay methods (Hong, Kim et al., 2003).  The saNOS was 
found to be a heterodimer with masses of 64 and 67kDa determined by SDS-PAGE (Hong, 
Kim et al., 2003).  The Nocardia studies showed NOS activity via L-[3H]Arginine and the 
Griess assay.  Nocardia NOS was isolated as a homodimer of 51.9 kDa (Chen and Rosazza, 
1995).   
The ADP/L-Arg sepharose columns yielded varying results.  The eluates from both 
the ADP and the L-Arg sepharose columns had to be concentrated 20 fold to be detectable on 











SDS-PAGE with Coomassie.  The ADP-sepharose column alone isolated proteins of 30, 40, 
42, 44, 60 and 97 kDa.  The combination of ADP-sepharose followed by the L-Arg sepharose 
column gave two protein bands of approximate size 38 and 64 kDa.  Upon Western blot 
analysis, faint bands indicated reactivity with proteins of molecular mass 30, 34, 40, and 42 
kDa.  Some of these protein bands were too dilute to be detected with Coomassie but the 
immunoblot using mouse iNOS 1° Ab was able to detect their presence.  The bands exhibited 
in the immunoblot could be products of protein degradation, since they are all smaller than 
the 42 kDa bcNOS band and are all similarly immunoreactive.  It should be noted that the 1º 
Ab used was raised against the reductase domain of mNOS.  Thus the 38 and 64 kDa proteins 
evidenced in the Coomassie stained gel but not found on the immunoblot could be potential 
interacting protein partners to bcNOS.  This experiment was run twice, the first time no 
bound protein was found because the eluate was very dilute.  The 20 fold concentration of 
the eluate allowed for the visualization of the bound proteins.  These results were not found 
to be reproducible. 
The homogenization pellet was found to be immunoreactive, thus purification 
methods containing 0.25% Triton X-100 were attempted to determine if the reactive species 
could be solubilized with detergent and then purified by these methods.  SDS-PAGE results 
stained with Coomassie showed no proteins remained bound after both columns, however 
Western Blot analysis indicated two proteins of molecular mass 32 and 42 kDa bound both 
columns.  Again the smaller fragment found in the immunoblot could very well be a product 
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of proteolytic degradation of bNOS.  Table 2.2 compares the results obtained with and 
without Triton X-100 present.   
 
Figure 2.3–B. cereus lysate fractionated using ADP-sepharose and L-Arg sepharose consecutively.   
This figure compares these procedures preformed with out (A) and with (B) 0.25 % Triton X-100.  Lanes 1&2 
homogenization pellet and supernatant, respectively, Lanes 3-6 fractions from ADP-sepharose column, Lanes 7-
9 L-Arg-sepharose fractions, Lane 10 low molecular weight marker (20, 30, 45, 66, 97 kDa).  Lanes 6 & 9 were 
concentrated 20x prior to analysis.  Gel stained with Coomasie R-250. 
 
Another approach attempted for this method was to perform the L-Arg sepharose 
column first.  Since bcNOS is known to bind L-Arg this could provide evidence that those 
proteins that bound both columns are indeed bNOS or interacting protein partners.  
Fractionations done in this manner resulted in several non-specific interactions with the L-
Arg-sepharose column and none with the ADP-sepharose column.  This is not entirely 
surprising as it is still unknown if the electron-donating partner would bind NADPH.   
Table 2.2 summarizes the results obtained during these attempts at isolating of intact 
bNOS protein complexes.  The size of protein bands and the methods by which they were 
isolated, as discussed previously, are reviewed in this table.  Since many proteins of various 
sizes are listed in this table, it may be useful to recall the bcNOS enzyme is 42-43 kDa 











(depending on the presence of a His-tag).  The presence of a band at 42-43 kDa as well as 
other proteins could indicate the presence of protein-protein interactions.  The presence of 
mouse iNOS immunoreactive band confirms the 42-43 kDa protein as having NOS-like 
structural characteristics.  Unfortunately, these results do not point conclusively to one or two 
probable interacting proteins.   
Table 2.2- Summary table of efforts to isolate intact bNOS protein complexes from native sources. 
Molecular weight of each protein isolated by the different chromatographic techniques, as described in detail in 
the text, are given in kDa.  Replicates of the same chromatographic techniques are shown in separate rows.  
Results for samples resuspended in buffer containing 0.25 % Triton X-100 are also listed in separate rows.  




sepharose Mono Q Sephacryl 300 
Cell lysate resuspended in buffer without Triton 
Coomasie stain     
many 
bands 30/32/42/60/66 
  60       
  42/44/60/97       
  30/42/64 38/64     
  None       
          
Western with anti MiNOSa 40/66 30/40     
  30/66 34/42     
     
Cell lysate resuspended in buffer with 0.25 % Triton X-100 
Coomasie stain  42/60/64 none     
         
Western with anti MiNOSa 42/66 32/40     
a C-terminal NADPH binding domain (residues 961-1144) of mouse iNOS 
 
The ADP / L-Arg-sepharose method shows promising results, since it yielded a 
limited number of proteins.  The ADP-sepharose column produces a protein band appropriate 
to bcNOS plus bands of approximated size 30, 44, 60, 64, 66, 97 kDa.  Although these 
proteins may interact with NADPH, it is still unclear if they interact with bNOS.  Since the 
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ability of the bNOS electron-donating partner to bind NADPH is still unknown, other 
methods were pursued. 
2.3.3 Probing Protein-Protein Interactions of bNOS 
The second approach taken to determine probable electron donors for bNOS was to 
‘fish-out’ interacting proteins using the known overexpressed bNOS protein as bait.  These 
methods entail binding His-tagged bNOS protein to a resin and allowing cell lysate to 
interact with the bound protein.  The column is subsequently washed and any interacting 
proteins elute with the His-tagged protein.  Three different resins were used to accomplish 
these studies: Ni2+-chelating resin, Pull-down kit Co2+-chelating resin, and metallic Co2+-
chelating resin. 
The Ni2+-chelating resin was used first due to availability.  The column was 
overloaded with the bcNOS bait protein to ensure that proteins in cell lysate would bind only 
if they interacted with the bait protein and not with the resin.  Figure 2.4 shows the protein 
fractions obtained from Ni2+-chelating column run with bcNOS bait and B. cereus cell lysate.  
Although faint bands of possible interacting proteins are evident, the overloading of the bait 
protein masks any proteins in the 40 kDa region during elution with imidazole.  These 
methods have produced possible interacting proteins of size 32, 38, 40, 42, 45, and 60 kDa.  
The 42 kDa protein could be bcNOS and the other proteins are potential interacting partners.  




Figure 2.4– Pull-down experiment using bcNOS bound to Ni2+-chelating column.  
Lane 1 cell pellet, lane 2 cell lysate, lane 3 bcNOS cell lysate flowthrough, lane 4 buffer wash, lane 5 low 
molecular weight marker, lane 6 bcNOS, lane 7 cell lysate buffer wash, lanes 8-10 eluted fractions.  Gel stained 
with Coomasie R-250. 
 
The bound fraction from the Ni2+-chelating column was followed by a 2’5’-ADP- 
sepharose column to determine if any of proteins that bound to the His-tagged bait would 
also bind the ADP-sepharose resin.  No proteins were detected by SDS-PAGE with 
Coomassie staining.   
A Pull-Down kit was obtained from PIERCE in attempts to exploit its optimized 
conditions for ‘fishing out’ any interacting proteins.  The main differences between this 
system and the homemade pull-down experiment were the method of lysing the cell culture 
with their proprietary detergent, the reduction in amount of cell lysate used to probe the 
possible interactions, and the reduction of salt in the wash buffers.   
The PIERCE Pull-Down kit yielded a single protein band of approximately 40 kDa 
that eluted at the same time as the His-taged bcNOS.  Figure 2.5 shows a comparison of the 
bound fractions of the bait (previously purified bcNOS), the prey (B. cereus cell lysate) and 










bait plus prey.  Non-specific interactions with the Co2+-chelating column that are found in the 
prey elution are minimized by overloading the column with the bait.  The interaction appears 
to be disrupted with 500 mM salt eluting some of the bait protein as well as an additional 
band at 40 kDa.  With subsequent elution with imidazole, the whole 38-42 kDa region is 
overshadowed by the abundance of bcNOS.  Although the 40 kDa protein should be further 
analyzed, this method did not prove to be significantly more fruitful than the homemade pull-
down experiment with Ni2+-chelating chromatography. 
 
Figure 2.5 – Pull-down experiment using bcNOS bound to Co2+-chelating column.   
Lane 1 low molecular weight marker, lane 2 purified bcNOS, lane 3 prey flowthrough, lane 4-6 prey salt 
elutions 100, 250, 500mM, respectively, lane 7 bait + prey 500mM salt elution, lane 8 bait 500mM salt elution, 
lane 9 bait imidazole elution.  Gel stained with Coomasie R-250. 
 
Another method that was explored was the use of Dynabeads® TALON™ 
magnetizable beads used in Co2+-based immobilized metallic affinity chromatography to 
isolate His-tagged proteins.  This magnetic resin uses less vigorous separation conditions 
which is useful for pull-down experiments.    This method uses the same principles for 














‘fishing-out’ interacting proteins as the other two His-tagged methods however uses less 
vigorous methods for washing and elution.  The less vigorous methods may allow protein-
protein interactions that are disrupted by other methods to remain intact.    
The magnetic resin resulted in significant non-specific binding.  Although saturating 
the column with purified His-tagged bcNOS disrupts some of the non-specific binding many 
proteins remain.  A comparison of those proteins found in the prey negative control elution 
and those found with the bait plus prey was performed to identify any potentially interacting 
partners.  All potential interacting partners appear to be in the negative control.  More 
sensitive methods for detection would be needed for this comparison.   
 
Figure 2.6– Purification fractions from magnetic resin.   
Lane 1 low molecular weight marker, lane 2 previously purified bcNOS, lane 3 prey imidazole elution, lane 4 
bait + prey imidazole elution, lane 5 prey 500mM salt elution, lane 6 bait + prey 500mM salt elution, lane 7-9 
imidazole elution for bait, prey, and bait + prey, respectively.  Gel stained with Coomasie R-250. 
 
The results from the bcNOS pull-down experiments are summarized in Table 2.3. The 
Ni2+- and Co2+-chelating columns did not yield significant reproducible binding proteins.  












The magnetic Co2+-chelating column produced many but reproducibly binding proteins.  The 
less vigorous separation methods do not disrupt interactions with proteins in the cell lysate.  
Many of these binding proteins are interacting non-specifically with the resin, however 
further analysis could pull-out interacting partners not found in the negative control.   
Table 2.3– Summary table of pull-down experiments using His-tagged bcNOS as bait immobilized on 
different metal-chelating resins. 
Molecular weight of each protein isolated by the different chromatographic techniques, as described in detail in 
the text, are given in kDa.  Replicates of the same chromatographic techniques are shown in separate rows.  
Results for samples resuspended in buffer containing 0.25 % Triton X-100 are also listed in separate rows. 







Cell lysate resuspended in buffer without Triton 
Coomasie stain 32/38/42     
  40/45/60     
  43     
    many bands*   
    40/42   
      many bands* 
      many bands* 
Cell lysate resuspended in buffer with 0.25 % Triton X-100    
Coomasie stain      many bands* 
    
Western with anti MiNOSa       
    inconclusive* inconclusive* 
  34/42     
  34/42     
* - non-specific binding  
  aC-terminal NADPH binding domain (residues 961-1144) of mouse iNOS 
2.3.4 Bacterial NOS Activity 
Crude activity assays of these fractions were performed by monitoring NO production 
using the Griess Assay.  Indications of activity were found in the homogenization pellets as 
well as the concentrated eluted fractions.  However, since the activity readings were only 
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approximately twice the blank reading, this method was not pursued further.  Since the 
binding affinity for NOHA is much higher than that of L-Arg in bacterial NOS enzymes, the 
substitution of NOHA for L-Arg in the enzyme mixture was attempted.  This did not result in 
the increase in activity of the samples.  Some studies also suggest that CaM is required for 
maximal activity (Adak, Aulak et al., 2002; Adak, Bilwes et al., 2002).  While presently 
there is no known physical basis for this requirement in vivo, CaM was added to some assay 
mixtures to determine if the activity found in the samples would increase.  As expected the 
addition of CaM did not significantly improve the apparent activity in the samples.  The 
effect observed by Adak et al. in 2002 could be due the utilization of mNOS reductase as the 
electron donor for the bNOS assay.   
Methods utilizing the addition of NADPH as an electron donor were also investigated 
but did not result in an increase in activity above background. 
The activity assay used for assaying the fractions is presently unreliable.  It would be 
desirable to be able to follow the activity during the purification process.   
2.4 Concluding Remarks 
The present studies did not yield conclusive evidence for specific interacting electron 
donating partner.  New methods need to be pursued due to the inability to follow the elution 
of potential interacting partners.  Since activity in the eluted fractions is undetectable and the 
identities of the potential interacting partners are unknown, no specific characteristics can be 
used to determine their presence during fractionation.  Fractions often have to be 
concentrated 20 fold and fractions containing His-tagged proteins need to be overloaded in 
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order to be able to detect any potential interacting proteins by SDS-PAGE.  The present 
method of detection of NOS activity is also not sensitive enough to follow activity within the 
eluted fractions from chromatographic techniques.  Since chromatographic techniques often 
yield many fractions without a method of following the location of the target protein the 
processing of samples quickly becomes very labor intensive.     
The ultimate goal would be to isolate several proteins of interest and to identify these 
interacting partners using mass spectrometry.  This could prove to be difficult if these 
proteins of interest are found in low abundance, as the techniques we currently have to 
identify proteins (mass spectroscopy) require enough protein to be visualized on a Coomassie 
stained gel. 
2.5 Future Directions 
Future directions for this project could include isolation of intact protein complexes 
under native conditions.  Two methods could be used to take this approach: (i) Expression of 
bNOS with a tag in the native bacterial strain, (ii) Utilization of a yeast two-hybrid system. 
2.5.1 Expression of Tagged-bNOS in Native Conditions 
One method of probing interactions in the native conditions is to express a tagged 
bcNOS in B. cereus.  Table 2.4 lists expression vectors for use in Bacillus strains.  The 
pMUTIN vector series with tags allows insertion of the tag under the control of the native 
promoter.  This series of vectors may not allow for the overexpression of the target protein 
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but should result in the proper proportions of target protein and interacting partners.  The 
protein complex can then be isolated by immunoprecipitation or by affinity chromatography.   
Table 2.4– Bacillus expression vectors 
Expression 





          
pMUTIN-Flagd Cloned locus Em   Pspac 
pMUTIN-FAd Cloned locus Em   Pspac 
pMUTIN-GFPd Cloned locus Em   Pspac 
pMUTIN-CFPd Cloned locus Em   Pspac 
pMUTIN-YFPd Cloned locus Em   Pspac 
          
pSWEETe amyE   Pxyl   
pHCMC02d 
Extra 
chromosomal Cr PlepA   
pHCMC04d 
Extra 
chromosomal Cr Pxyl   
pHCMC05d 
Extra 
chromosomal Cr Pspac   
pHT304f 
Extra 
chromosomal Em PlacZ   
aResistance – erythromycin (Em), chloramphenicol (Cr) 
bUptream promoters - xylose inducible promoter (Pxyl), weakly constitutive promoter (PlepA), IPTG inducible 
(Pspac) & (PlacZ) 
cDownstream promoter – IPTG inducible (Pspac) 
dBGSC – Bacillus Genetic stock center 
e(Bhavsar, Zhao et al., 2001) 
f(Arantes and Lereclus, 1991) 
 
Alternatively, the pHCM vector series would allow for the overexpression of a cloned 
gene extra chromosomally.  A fusion protein could be cloned into one of these plasmids to 
allow for immunoprecipitation or affinity chromatography.  The expression could be carried 
out in the bcNOSKO strain to remove competition for the electron donating partners from the 
natively expressed bcNOS protein.   
 Extracting interacting partners from native conditions may prove to be more fruitful 
than trying to induce these interactions to protein already bound to a solid support.   
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2.5.2 Yeast 2 Hybrid System for B. subtilis 
Another possibility for probing protein-protein interactions would be to use a yeast 
two-hybrid system.  Yeast two-hybrid systems rely on two plasmid-borne gene fusions 
cotransformed into a yeast strain containing an inducible reporter gene (James, Halladay et 
al., 1996).  The bait protein is fused with a DNA binding domain specific to the reporter gene 
contained in the host strain.  The expression library contains proteins fused to a 
transcriptional activation domain.  Interactions of the two proteins in the host strain leads to 
activation of the reporter gene.  Expression libraries are screened by looking for this 
phenotypic response.   
A yeast two-hybrid system has been created recently for B. subtilis (Soppa, 
Kobayashi et al., 2002).  Probing protein interactions in this manner would allow for the 
identification of less stable interactions than those required for positive identification in this 








Chapter 3: Investigations into the Role of bNOS 
3.1 Introduction 
Due to the physiological and pathological importance of mNOS it is believed that 
bNOS may play a critical role in bacterial systems.  Although the presence of a NOS-like 
protein in prokaryotic systems is attracting increasing interest, a functional role has yet to be 
assigned to this intriguing enzyme.  Possible roles for this enzyme, as described in detail in 
chapter 1, could include: (i) intercellular signaling to coordinate cellular/infectious activity, 
(ii) regulation via NO-mediated posttranslational modifications, or (iii) nitration of 
compounds in different biosynthetic pathways.   
The methods used to investigate bNOS enzymes have focused on in vitro 
characterization of recombinantly expressed protein.  Little effort has been devoted to the 
determination of a physiological role for this gene.  A recent study by Gusarov and Nudler 
has suggested that the bNOS gene may mediate cellular adaptation to oxidative stress.  They 
showed wild type strains of both B. subtilis and S. aureus were more resistant to oxidative 
stress than bNOS knockout strains.  They suggest two mechanisms of cytoprotection: (i) via 
up-regulation of catalase, and (ii) via suppression of available cellular reducing agents, which 
sustain the production of damaging oxidizing agents (Gusarov and Nudler, 2005).   
In order to understand the impact of this gene within bacterial systems, a genetic 
knockout of bNOS was obtained and characterized.  One method of exploring the possible 
role of NOS-like enzymes in bacterial systems is to look at the differential protein expression 
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due to the knockout of the bNOS gene.  Two-Dimensional Differential Gel Electrophoresis 
(2D-DIGE) allows for the determination of the change in protein expression exhibited 
between two samples.  This technology was setup in our lab and used to identify changes in 
protein expression due to this genetic knockout.  This will give clues to the role this gene 
may play in bacterial systems.  
3.1.1 Gene Knockout 
Genetic knockouts of the gene of interest were obtained in both B. subtilis and B. 
cereus.  The knockouts were accomplished by insertional mutagenesis using the multi-host 
vector pMUTIN4 shown in Figure 3.1. This vector is uniquely designed for cloning in E. coli 
and insertional mutagenesis in other species.  This vector relies on the cloning of an internal 
fragment of the target gene into the multi cloning site (MCS).  Homologuous recombination 
of this fragment with the chromosomal DNA results in the entire vector being inserted into 




Figure 3.1– Schematic of homologous recombination of pMUTIN4 and with the targeted chromosomal 
DNA resulting in insertional mutagenesis. 
Plasmid contains a origin of replication (ori) and an ampicilin resistance marker (ApR) for cloning in E. coli.  
After insertion into the target locus, the reporter gene (lacZ) and the erythromycin resistance marker (EmR) are 
placed under the control of the promoter of the gene of interest.  This event puts a stop codon in the middle of 
the gene of interest and places the downstream elements under the control of an IPTG-inducible promoter 
(Pspac).  
 
 This plasmid is unable to replicate in B. subtilis, allowing for this recombination 
event to occur.  The pMUTIN4 vector contains a reporter gene, a selectable marker, a stop 
codon and an inducible promoter (Vagner, Dervyn et al., 1998).  The lacZ reporter gene is 
put under the control of the target gene’s promoter, allowing for monitoring of the expression 
of the target gene.  The selectable marker, erythromycin resistance, allows for the selection 
of recombinants.  Stop codons are incorporated in all three reading frames to ensure 
disruption of expression of the target gene.  Finally, the downstream elements are placed 
under control of the IPTG inducible promoter, Pspac.  The control of these downstream 




3.1.2 2D Gel Methodology and Limitations 
2D gel electrophoresis allows for a comprehensive study of the change in protein 
expression between two systems.  This technique has the potential to yield a view into the 
physiological impact of the system that is being studies.  However, this technique has some 
limitations.  The limitation of 2D gel methods are primarily caused by the complexity of the 
samples being studied, requiring extensive sample preparation and trouble shooting.  Sample 
preparations are extensive to ensure maximal protein solubility and to minimize 
contaminants which lead to difficulties with protein separation.  Presently there are no 
universal parameters for 2D gel separation.  Guidelines do exist for determining parameters, 
however, these parameters are time consuming to trouble shoot.   
Perhaps the greatest challenge to 2D gel users has been gel to gel variability leading 
to complicating analysis and experimental variability.  The introduction of the Ettan DIGE 
system from GE Healthcare allows for the incorporation of an internal standard in each gel 
allowing for gel to gel variability to be accounted for.   
3.1.3 DIGE 
The comparison of the proteomes of the knockout and wild type cultures was 
accomplished using 2D-DIGE.  The introduction of the Ettan DIGE system by GE 
Healthcare has revolutionized 2D gel proteomic methods.  Previous 2D gel methods were 
plagued with reproducibility issues.  The Ettan DIGE system is based on matched intrinsic 
properties of three fluorophores which allows for multiplexing of three samples on the same 
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2D-gel.  The multiplexing of multiple samples on the same gel allows for an internal standard 
to be run on each 2D-gel.  This system allows for quantitative data supported by statistics to 
ensure that the results obtained are not due to experimental variation. 
The cyanine based CyDyes™ from GE Healthcare are presently the best system for 
this application.  The labeling procedure for the three CyDye™ DIGE fluors (Cy2, Cy3, and 
Cy5) shown in Figure 3.2, are designed so that the same protein labeled with different CyDye 
DIGE fluors will migrate to the same position on a 2D gel.   
 
Figure 3.2-Structure of Cy3 (A) and Cy5 (B) fluors used in differential in-gel eletrophoresis. 
(Taken from GE Healthcare CyDye Chemistry manual) 
 
The dyes used in DIGE are specially designed to minimize the alteration of the 
intrinsic properties of the proteins. The fluorescent label adds only ~500 Da to the molecular 
weight (MW) of the protein, creating a minimal mass shift on the electrophoresis gel.  The 
dye is limited in the labeling reaction so that only ~1-2 % of the lysine residues (Lys) are 
labeled.  Since the average abundance of lysine in proteins are 3-5 %, the dyes are designed 
such that each protein that is labeled will only be singly labeled, thus minimally affect the 
system that is being studied.  
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The three CyDyes™ in conjunction with the Typhoon 9400 variable wavelength 
imager, allows for the comparison of two samples and one internal standard on the same gel.  
The pooled internal standard, which is a pool of all samples of the system that is being 
studied, is used to both match the protein spot pattern and to standardize quantitation.  The 
deconvolution of these images is possible using the DeCyder software which corrects for 
variability between gels using the internal standard and then overlays the gel images.   
The result of these methods is a differential spectrum between the two proteomes.  
The Ettan DIGE system allows for the accurate determination of the change in protein 
expression by as little as 10 % with greater than 95 % statistical confidence.  The sensitivity 
of the CyDyes allow for the detection of as little as 125 pg of a single protein with a linear 
response of up to five orders of magnitude.  A minimum of three replicates is used to 
determine the statistical relevance of the change.  The Student’s T-test values are determined 
based on the log of the ratio of change between the two systems.  Proteins that are found to 
be significantly differentially expressed in the two systems can be excised from the gel and 
are identified using mass spectrometry (MS).  These methods have improved reproducibility 
of results which has allowed for the development of databases which are invaluable when 




3.2.1 Bacterial Strains and Growth Conditions 
B. subtilis wild type strain 168 (trp C2) (Burkholder and Giles, 1947) was obtained 
from the Bacillus Genetic Stock Centre and the isogenic mutant strain, yflMd, was obtained 
from Dr. Junichi Sekiguchi, Shinshu University.  B. cereus wild type strain 14579 was 
obtained from the American type culture center.  All strains and plasmids are listed in Table 
3.1.  Cells were grown in SG media without glucose supplementation (8 g Difco Bacto 
Nutrient Broth, 1 g KCl, 0.25 g MgSO4·7 H2O, pH to 7.0 with 1 M NaOH, autoclaved, 
cooled to 55◦C, then add 1 mM CaCl2, 0.01 mM MnCl2·H2O, 1 μM FeSO4) (Leighton and 
Doi, 1971) at 200 rpm and 37ºC.  The mutant strains were maintained in media supplemented 
with 1 μg/mL erythromycin and 25 μg/mL lincomycin.  Cells were harvested by 
centrifugation (8000xg for 10 min at 4°C) according to peak expression of the yflM gene, 
determined by methods outlined below.  Cell pellets were washed 3 times with ice-cold TE 









Table 3.1– Bacterial strains and plasmids 
Bacillus strains   
   
Bacillus subtilis   
Strain or plasmid Relevant genotype Source* 
BGSC 1A1 Bacillus subtilis 168 (trp C2) BGSC 
yflMd NOS homologue knockout Dr. Junichi Sekiguchi, Shinshu University 
   
Bacillus cereus   
ATCC 14579 Bacillus cereus 14579 ATCC 
bcNOSKO NOS homologue knockout This study 
   
E.coli strains Molecular use  
DH5α Used for cloning Invitrogen 
XL1-Blues Used for PCR mutagenesis Stratagene 
   
Plasmids   
pMUTIN 4 Insertional mutagenesis vector Etienne Dervyn, INRA 
pHCMC02 Gram-positive expression vector BGSC 
pHCMC04 Gram-positive expression vector BGSC 
pHT 304 B. cereus/E. coli shuttle vector Didier Lereclus, INRA 
*BGSC - Bacillus Genomic Stock Center  
INRA - Institut National de la Recherche Agronomique 
3.2.2 Knockout Vector 
An 800bp fragment generated from B. cereus ATCC 14579 using PCR primers 
B.cereus14579NOSKOFor1 and B.cereus14579NOSKORev was obtained using the 
following PCR protocol using PWO polymerase (Roche): Initial denaturation 3 min at 85º, 
35 cycles of 1.5 min at 95ºC, 2.5 min at 68ºC, and 1 min at 72ºC. The final extension was 
carried out at 72ºC for 15 min.  The fragment was cloned into the pMUTIN4 vector, using 
the HindIII and BamHI cut sites (ratio 10:1 molecules most effective for cloning).  Plasmids 





Table 3.2 – Primers used for cloning, mutagenesis, and knockout verification. 
B.cereus NOS knockout oligos  
B.cereus14579NOSKOFor1  5’CGGGGGAATTCTTGTTATAAGGAGCTTCATAAAGAACAA 3’  
B.cereus14579NOSKORev  5’ CACCTGGATCCCAGCAGTATGGTGATCAACAATACTAACTC 3’ 
B.cereus PCR mutagenesis oligos  
Cysteine mutation bc14579 For 5’GGCATGGCGTAACAGTAATCGATTGATTGGAAGACTATTTTGGAG 3’ 
Cysteine mutation bc 14579 Rev 5’CTCCAAAATAGTCTTCCAATCAATCGATTACTGTTACGCCATGCC 3’ 
Knockout verification oligos  
bsNOSFor  5’ GAAGATCTCATATGGAAATACTCTGGAACGAAGCGAAAGCG 3’ 
bcNOSFor  5’ CGGGGAAGCTTATGAGTAAAACGAAACAATTAATAGAAGAA 3’ 
 
3.2.3 PCR Mutagenesis 
The Quick change method (Wang and Malcolm, 1999) was used to mutate Cys to 
Leu.  PCR mutagenesis was performed using cysteine mutation bc14579 For and Cysteine 
mutation bc 14579 Rev primers and the following protocol with Expand Longtemplate 
polymerase (Roche): Two half reactions were setup with one primer in each.  The program 
included a Hot start, an initial denaturation of 5 min at 95ºC, 5 cycles of 1 min at 95ºC, 1 min 
at 65ºC, and 10 min at 68ºC. The program was paused, and the two half reactions were 
mixed.  The program continued with 12 cycles of 1 min at 95ºC, 1 min at 65ºC, and 10 min at 
68ºC.  The final extension was carried out at 68ºC for 15 min.  The reaction mixture was 
digested with DpnI for 2 hrs at 37ºC and heat inactivated for 30 min at 80ºC.  The reaction 
mixture was transformed into XL1-Blues, mini-prepped and digested with ClaI prior to 
sending for confirmation by sequencing. 
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3.2.4 Gene Knockout 
Electrocompetent cells were prepared by methods outlined previously (Silo-Suh, 
Lethbridge et al., 1994).  Briefly, 100 mL LB was inoculated with 1 mL of overnight culture 
and then grown to an OD600 of 0.3 (~90 min).  Cells were harvested at 3000xg for 5 mins at 
4ºC.  Cells were resuspended in 12 mL EP buffer (0.5 mM K2PO4/KH2PO4, 0.5 mM MgCl2, 
272 mM Sucrose) and centrifuged as before.  Cells were then resuspended in 200 µL EP 
Buffer and stored on ice until use.  40 μL cells were transformed with 0.1 to 1µg of DNA in 
1mm cuvettes using 1.2 & 1.8 kV.  Cells were recovered in 1.5 mL LB at 30ºC for 5 hours 
and then 100 µL & 500 µL aliquots were plated on LB plates containing 1 µg/mL 
erythromycin and 25 µg/mL lincomycin.  Plates were grown for 2 days at 30ºC.   
3.2.5 Verification of Knockouts 
Colony PCR screening was performed using the primers used for cloning the gene 
and for knocking out the gene bsNOSFor and bsNOSRev for B. subtilis yflMd, and  
bcNOSFor and bcNOSRev for B. cereus bcNOSKO, knockout strains respectively. Colony 
PCR (1 colony resuspended in 50-100 µL of sterile MQ) using Expand Long Template 
Polymerase (Roche) was performed in buffer 2 using a Touchdown program with annealing 
temperatures 68-58ºC and an extension of 15 min. 
3.2.6 Expression Test 
The yflMd strain includes a β-galactosidase (β-Gal) reporter gene under the control of 
the yflM promoter.  The β-Gal activity was monitored by methods outlined by Yoshida et al. 
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in 2000 modified to a microtitre plate assay.  Cell pellets were resuspended in 250µL Buffer 
Z (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1mM MgSO4, 1 mM DTT, 10 µg/mL 
DNase I, 100 µg/mL Lysozyme) and incubated at 37ºC for 1 hr.  B. cereus cells were 
sonicated 3 times for 10 seconds.  Tubes were centrifuged at 13, 000 rpm at 4ºC for 20 min.  
In a microtitre plate 20 µL of sample was mixed with 80 µL Buffer Z and incubated at 4ºC 
for 10 min.  20 µL of 4 mg/mL o-nitrophenol-β-D-galactopyranoside was added to initiate 
the reaction.  The reaction mixture was allowed to incubate for 1 hr at r.t. before stopping 
with the addition of 50 µL 1 M Na2CO3.  The absorbance was read at 420 nm and a standard 
curve was generated using 0-120 nmol 2-nitrophenol (stock 10 mM in EtOH).  β-Gal activity 
was determined in nmol of product/min (mg protein)-1 (Atkinson, Wray et al., 1990; 
Yoshida, Ishio et al., 2000).  
3.2.7 Griess Assay 
The release of ·NO into the medium was measured using the Griess assay (Griess, 
1864; Ignarro, Buga et al., 1987) modified to a microtiter plate reader assay.  Briefly, 100 μL 
of media was incubated with 100 μL of Griess reagents at 25ºC for 10 min and then read at 
540 and 630 nm using a SPECTRAmax PLUS 384 microtiter plate reader.  The Griess 
reagents comprise a 1:1 ratio of freshly prepared 0.1 % naphthylethylenediamine (N5889, 
Sigma-Aldrich Canada Ltd., Oakville, ON) in MQ water and freshly prepared 1 % 
sulphanilamide (S9251, Sigma-Aldrich Canada Ltd., Oakville, ON) in 5 % phosphoric acid 




3.2.8 Fluorometric Nitrite Assay 
Nitrite was assayed using Nitrate/Nitrite Fluorometric Assay Kit from Cayman 
CHEMICALS (Ann Arbour, MI).  Samples were withdrawn at peak bNOS expression, as 
determined by β-Gal activity, and incubated in the presence of 100 µM L-Arg for 30 min at 
37°C with shaking.  10-20 μL of the supernatant were diluted to 100 μL prior to the addition 
of the DAN reagent.  The reaction was incubated at room temperature for 10 min before the 
quenching of the reaction with 20 μL of NaOH stock from kit.  The samples were read at λex 
360 nm λem 430 nm in a microtiter plate reader. 
3.2.9 2D Electrophoresis Sample Preparation 
Unless otherwise stated all reagents and 2D kits were obtained from GE Healthcare 
(Baie d’Urfé, QC, Canada).  DNase I and RNase A were obtained from Roche.  Tris, Urea, 
DTT and CHAPS were obtained from Bioshop Canada.   
The pellet of 200 mL of cells was resuspended in 2 mL of Lysis buffer (30 mM Tris, 
pH 8.5, 8 M Urea, 2 M Thiourea, 4 % CHAPS) and sonicated on ice 3 times for 10 seconds.  
Cellular debris was pelleted at 48000xg for 30 min at 4°C.  The protein concentration was 
assessed using the 2D-Quant Kit.  The supernatant was treated with nuclease solution (0.1 
mg/mL DNase I, 0.025 mg/mL RNase A, 5 mM MgCl2).  Samples were flash frozen and 
stored at -80°C.  Protein samples were precipitated using the 2-D Clean-Up Kit from GE 
Healthcare and resuspended in rehydration buffer (8 M Urea, 2 M Thiourea, 1 % CHAPS, 
0.5 % IPG Bufer 3-10, 2 mg/mL DTT, Bromophenol blue).  Samples were loaded by 
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rehydration loading onto 24 cm 4-7 IPG strips (GE Healthcare) for 10-20 hrs at room 
temperature.  Analytical and preparative gel strips were loaded with 150 μg and 800 μg of 
protein, respectively.  Isoelectric focusing was performed using the Ettan IPGphor II (GE 
Healthcare) with the following program: 3 hrs at 300 V, 6 hr gradient to 1000 V, 3 hr 
gradient to 8000 V and 6 hrs at 8000 V.  Paper wicks were replaced after 6hrs during the IEF 
run to reduce salt build up at electrodes.  After successive equilibration with SDS 
equilibration buffer (50 mM Tris-HCl, pH 8.8, 6 M Urea, 30 % glycerol, 2 % SDS, 
Bromophenol blue) containing 1 % DTT and 2.5 % Iodoacetamide, for 15 min each, IEF 
strips were placed on the top of a SDS-PAGE gel and overlayed with a 1 % agarose solution 
and bromophenol blue in SDS running buffer (25 mM Tris-HCl, 192 mM glycine, 0.1 % 
SDS).  The lower buffer chamber was filled with 1X running buffer and the upper buffer 
chamber was filled with 2X running buffer.  Separation in the second dimension was 
performed using a 15 X 25 cm 12.5 % homogeneous polyacrylamide gels at 5 W per gel for 
1 hr and 17 W per gel for 3 hrs at 4ºC.  All solutions, including acrylamide solutions, were 
filtered through 0.2 µm filter prior to use. 
Analytical gel samples were labeled with CyDyes™ 2, 3 and 5 according to the 
manufacturer’s instructions (GE Healthcare).  Briefly, 50 μg precipitated protein samples 
were rehydrated in 10 μL of lysis buffer and incubated with 200 pmol of the appropriate 
CyDye™ in anhydrous DMF for 30 min.  The reaction was quenched with 10 mM lysine 
prior to addition of rehydration buffer.  All procedures involving the CyDyes™ were 
preformed at 4°C in the dark. 
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Each condition was run in triplicate alternating labeling with Cy3™ and Cy5™, to 
account for dye effects.  Each gel contained a Cy2™ labeled pooled internal standard.  Gel 
images were generated using the Typhoon 9400 Variable Mode Imager scanning at 100 
micron resolution at the appropriate wavelengths for each fluorophore:  Cy2™ λex 488 nm 
λem 520 nm, Cy3™ λex 532 nm λem 580 nm, and Cy5™ λex 633 nm λem 670 nm.  The gel 
images were cropped in Image Quant v2.0 and analyzed using DeCyder v2.0 2-D Differential 
data analysis software.   
Preparative gels were stained using Blue silver colloidal Coomassie G-250 stain by 
methods outlined by (Candiano, Bruschi et al., 2004). Briefly, stain was prepared to a final 
concentration of 0.12 % dye, 10 % ammonium sulfate, 10 % phosphoric acid, and 20 % 
methanol.  The stain was prepared by sequentially adding all ingredients except methanol.  
The solution was brought to 80 % final volume with water and mixed thoroughly prior to 
addition of methanol.  The colloidal suspension was stored in a dark bottle and resuspended 
prior to each use.  The solution is stable at room temperature for > 6 months but can only be 
reused 2-3 times.  Gels were stained overnight and destained in water until the background 
was adequately destained. 
Trouble shooting analytical gels were stained with Deep Purple Total Protein stain 
(GE Healthcare).  Gels were fixed with fixation solution (7.5 % acetic acid in 10 % 
methanol) overnight.  Gels were washed with wash solution (35 mM NaHCO3, 300 mM 
Na2CO3).  A 1:200 dilution of Deep Purple stain in water was then added and incubated in 
the dark with gentle shaking for 1 hr.  Gels were washed twice in 7.5 % acetic acid for 30 
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min each and then imaged on the Typhoon 9400 scanner λex 532 nm λem 610 BF scanned at 
100 microns resolution. 
3.2.10 IPTG-Induction of Downstream Elements 
In order to distinguish between the effects due to the expression of the target gene and 
the downstream elements, the downstream elements were put under the control of an IPTG-
inducible promoter.  A comparison was made between the change in expression between the 
wild type and the knockout with and without IPTG-induction.  Those protein spots that 
significantly changed (p ≤ 0.01, │Fold change│ ≥ 2) in both the one gene knockout and the 
knockout with induction of the downstream elements were picked by hand and prepared for 
MS analysis.   
3.2.11 MS Sample Prep and Analysis 
Protein spots were picked by hand, destained and digested with sequencing grade 
trypsin (Promega, Madison, WI, USA) by methods adapted from (Wilm, Shevchenko et al., 
1996).  Gel slices were cut into cubic millimeter fragments and washed 3 times with ultra 
pure water (5 min each).  The gel fragments were then washed 3 times with 50 mM 
ammonium bicarbonate in 50% acetonitrile (10 min each).  The gel fragments were 
dehydrated by washing with 100 % acetonitrile for 5 min prior to incubation with 10 mM 
DTT in 100 mM ammonium bicarbonate for 30 min at 50°C to reduce the proteins bound in 
the gel.  All liquid was removed and the gel fragments were again dehydrated with 100 % 
acetonitrile prior to incubation with 55 mM iodoacetamide in 100 mM ammonium 
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bicarbonate in the dark for 30 min at room temperature to alkylate the proteins.  The gel 
fragments were washed with 100 mM ammonium bicarbonate for 15 min and then 
dehydrated once more with 100 % acetonitrile.  Proteins were then digested with 80 ng 
Trypsin in the presence of 100 mM ammonium bicarbonate for 16-18 hrs at 37°C.   
The peptides were then extracted and purified using C18 zip-tips according to 
manufacturer’s instructions (Millipore, Bedford, MA, USA).  Briefly, the peptides were 
extracted 3 times from the gel fragments using 5 % formic acid in 50 % acetonitrile with 
sonication for 5 min.  Sample volume was reduced to 10 μL prior to purification with C18 
zip-tips.  Zip-tips were equilibrated with 50 % acetonitrile (3 times) and then 0.1 % formic 
acid (3 times).  The peptides were bound to the tip by repeated pipetting (minimum 10 
times), washed twice with 0.1 % formic acid and then eluted by repeated pipetting (minimum 
10 times) using 50 % acetonitrile.  Formic acid was added to the samples to a final 
concentration of 0.2 % v/v formic acid.  All plastics were washed with Acetonitrile followed 
by ultrapure water (HPLC grade water from Fisher) to avoid PEG contamination of peptide 
samples. 
MS/MS data was collected using Micromass Q-TOF Ultima Global mass 
spectrometer in +ESI mode.  Protein identification was performed using MASCOT MS/MS 
ion search (Matrix Sciences) to probe the MSDB protein database using raw MS/MS data.  
PMF data was collected using Reflex III MALDI-TOF 337 nm Nitrogen laser (Bruker 
Daltonics).  Protein identification was performed using ProFound PMF search (PROWL) to 
probe NCBI database using peptide mass maps. 
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3.3 Results  
3.3.1 Knockout Characterization 
3.3.1.1 Knockout Verification 
The yflMd knockout strain (yflMd) was verified using the primers used to clone the 
bsNOS gene.  These primers amplified a fragment of approximately 10 kbp.  The 
transformation efficiency is so low in B. cereus the size of the internal fragment required to 
ensure that the homologuous recombination event occurs is much larger, 800 bp instead of 
200 bp in B. subtilis.  Since the bcNOS gene is only 1000 bp there is concern that the 
partially expressed bcNOS gene may still be active.  To rectify this, the Cys residue that is 
one of the heme ligands, was mutated to a Leu in the knockout vector prior to integration into 
the chromosome.  Replacement of this ligand in mNOS enzymes results in a loss of the heme 
and catalytic activity (Chen, Tsai et al., 1994; Richards, Claque et al., 1996; Cubberley, 
Alderton et al., 1997).  The bcNOSKO was verified using analogous methods for the yflM 
knockout with similar results of 11 kbp fragment. 
 
Figure 3.3 – PCR verification of NOS knockout. 
Lane 1 Gene Ruler 1 kbp DNA Ladder and lane 2 shows the amplification of a faint band at 1 kbp and an 








Proteomic studies in B. subtilis were begun while the B. cereus NOS knockout was 
being generated.  Efforts continued in the B. subtilis systems due to extensive databases that 
are available for this organism.  The abundance of peptide mass fingerprint (PMF) data bases 
allows for simplification of MS analysis.  These databases alleviate the need to sequence 
peptide fragments, allowing for the identification of proteins in a more expedited manner.  
The specifics of these identification methods will be discussed in more detail in section 3.3.4.   
3.3.1.2 Evaluation of bNOS expression in liquid media 
The ideal growth media for the induction of bsNOS was initially determined using the 
β-Gal reporter gene.  Since expression of this gene had been shown to be stress-induced, 
various media were initially tested.  S. aureus NOS has been previously shown to be induced 
in nutrient broth containing 0.125 % methanol (Choi, Seo et al., 1998).  The yflMd knockout 
was shown to express the β-Gal reporter gene only in sporulative media 
(http://bacillus.genome.jp/).  The knockout yflMd strain cultures were grown in SG, MM, 
DSM, MeOH, starvation (long growth in SG) media and β-Gal activity was determined for 
aliquots withdrawn hourly.  The most significant activity was found in the cultures grown in 
SG and MeOH media.  Since there was no significant difference found between these two 
conditions, subsequent growth trials were done using SG media. 
Growth trials were performed to determine when this gene was expressed and if NO 
was released into the media.  Both wild type and knockout cultures were grown and analyzed 
for β-Gal activity and for the presence of nitrite using the Griess assay.  The expression of β-
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Gal activity, as evidenced in Figure 3.4, indicates that this gene is expressed in late 
exponential phase and early lag phase.  
Other growth trials, including those posted on the web by the Sekiguchi group 
(http://bacillus.genome.jp/), also show expression in late exponential phase and early lag 
phase.  Samples for 2D-DIGE analysis were withdrawn late in log phase, as indicated by the 
arrow in Figure 3.4, to ensure yflM was being expressed at the time of analysis. 
Although the expression of the gene was evidenced by the β-Gal activity, no changes 
in nitrite levels were detectable in the supernatant using the Griess assay.  Figure 3.4 also 
shows the nitrite levels in the supernatant measured using the Griess assay.  There is no 
consistent trend exhibited between the knockout and the wild type system.  This could be 
indicative that the ·NO produced is used in biosynthesis and not released into the media or 



















































Figure 3.4– Expression of yflM during cell growth cycle exhibited by the β-galactosidase reporter gene 
activity.   
Arrows indicate the time of extraction of samples for 2D gel electrophoresis based on maximal activity of the 
reporter gene (β-Gal).  Nitrite levels, as determined by the Griess assay, are shown on the primary axis and are 
given in µM. 
 
A more sensitive method for detection of nitrite was used to investigate the later 
proposal.  A Fluorometric assay kit from Cayman CHEMICALS was used to detect 
differential nitrite levels between the knockout and wild type strains of B. cereus.  The assay 
showed slightly higher nitrite levels in the wild type strain compared to those found in the 
knockout, 3.31 µM and 2.66µM, respectively.  The relative difference between the wild type 
and the knockout are comparable to that shown previously by Gusarov and Nudler in 2005.  
Gusarov and Nudler compared the nitrite levels in the media of B. subtilis wild type and 
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bsNOS knockout strains and found the nitrite levels to be 20 % higher in the culture of the 
wild type strain.   
A comparative analysis is required to differentiate the increase in nitrite levels due to 
the low levels of nitrite and the presence of other nitrite sources.  Other sources of nitrite are 
found in the growth media and within the cell.  The most common source of nitrite in many 
denitrifying bacteria is Nitrate reductase and has been shown to be present in B. subtilis.  
Although bacteria are able to produce •NO via denitrifying pathways, the production of •NO 
is tightly regulated with •NO reductase to maintain the steady state of •NO at nanomolar 
levels (Cutruzzola, 1999).  Since nitrate reductase is repressed under conditions of nitrogen 
and oxygen excess (Ogawa, Akagawa et al., 1995; Nakano, Hoffmann et al., 1998), little 
nitrite should be derived from these pathways.  Since the nitrite levels are so low a 
comparative analysis gives confidence to the change in nitrite levels being real.   
3.3.2 2D Gel Trouble Shooting 
Initial 2D gel runs followed the recommendations of the manufacturer.  Amersham 
Biosciences recommended a rehydration buffer of 8 M Urea, 2 % CHAPS, 2 % IPG Buffer 
for maximal protein loads.  These recommended parameters resulted in very little protein 
entering the 2D gel.  The little protein that was able to enter the gel formed large horizontal 
streaks.  
Several parameters were varied in attempts to introduce more protein into the 2D gel.  
Different methods of sample loading, increased amount of protein loaded and increased 
amount of detergent, all resulted in similarly streaky gels.  Precipitation of the protein sample 
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prior to loading and increasing the IEF time from the recommend 25 kVhr to 80 kVhr, not 
only increased the amount of protein entering the gel but also increased the amount of 
streaks.   
Next the rehydration buffer was changed to a buffer used by Buttner et al. 2001 in a 
study of B. subtilis.  The rehydration buffer, containing 8 M urea, 2 M thiourea, 1% CHAPS, 
20 mM DTT, 0.5 % IPG buffer, significantly improved the solubility of the samples.   
Decreasing the amount of protein loaded and changing the IEF program to ramp up 
the voltage slowly while decreasing the total volt hours resulted in more distinct spots on the 






Figure 3.5– Analytical trouble shooting 2D gel image  
B.subtilis 168 sample, 200 μg of total protein separated on pH 4-7 IPG and 10 % SDS PAGE.  Gel stained with 
Deep Purple total protein stain.   
 
To further remove the salt from the sample and reduce salt build up at the electrodes, 
the cells were washed three times in TE buffer before harvesting and the paper wicks were 
replaced after 6 hours of IEF.  The samples were also treated with a nuclease solution to 
reduce interference of DNA and RNA in the IEF.  These measures improved the system to 
such an extent that well resolved proteins were obtained.  Figure 3.6 shows the results of a 
preparative gel of a protein sample from a wild type culture that has been induced with IPTG 





Figure 3.6 – 2D Preparative gel of wild type sample with IPTG.   
B.subtilis 168 sample, 600 μg of total protein separated on pH 4-7 IPG and 12.5 % SDS PAGE.  Gel stained 
with Blue silver stain.   
 
For more examples of trouble shooting 2D gel parameters the reader is referred to 
Section 3.4.1 and a discussion forum on the GE Healthcare website.  This is an invaluable 
tool for 2D gel users.  
3.3.3 Differential in-gel Electrophoresis Analysis 
Ettan DIGE system was used to determine the change in protein expression due to the 
bNOS gene in B. subtilis.  The Ettan DIGE system allows for the multiplexing of multiple 
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samples on each gel, allowing for an internal standard to be run on each gel.  The differential 
analysis of two samples can then be accomplished in an accurate quantitative manner by 
comparative analysis to this standard.  Over 1500 spots were detected and matched in the 
differential analysis compared to the 4100 open reading frames found in the B. subtilis 
genome, showing a good representation of the B. subtilis proteome.   
The DeCyder software allows for easy analysis of large proteomic data sets.  After 
the initial scan of the gels using the Typhoon variable wavelength scanner, the gel images are 
cropped and input into the DeCyder software.  The software detects and quantitates the 
protein spots on all of the gel images.  The software contains Differential In-gel Analysis 
(DIA) algorithms that detect spots based on matched images from the same gel.  This DIA 
not only ensures that all spots are represented in all the gels but also allows for quantitative 
comparison of spot volumes to the internal standard.   
The software also contains a Biological Variation Analysis (BVA) module which 
allows for inter-gel matching of protein spots and quantitative comparison of protein spots 
from multiple gels.  Once the gel images are input into the BVA, the gel that contains the 
greatest number of identified spots is chosen as the master gel and all other gel images are 
matched to the master.  At this point it is important for the user to ensure that the spot 
patterns have been matched appropriately.  Although the software automatically adapts the 
gel images to match the pattern of the master gel, spot matching can be adapted manually if 
needed.  Figure 3.7 is a screen view of the Match table of the BVA module, showing the 




Figure 3.7– Screen capture of the match table of the DeCyder 2D gel analysis software. 
(Refer to text for details) 
 
Once spot matching is complete, statistical analysis can be performed on the 
differential protein abundance levels between the systems.  Directing the software to 
compare to systems yields a Protein table in the BVA module that lists abundance ratios with 
statistical significance values attached.  The protein table, shown in Figure 3.8, allows the 
user to select proteins of interest and toggle between matched spots to ensure proper 
matching.  The lower left hand corner displays a 3D image of the spot pattern, showing 
relative protein abundances as peaks.  The upper right hand corner shows a graph of relative 
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abundance for a selected spot across all of the matched gels.  This gives the user an 
indication of the biological variance within the systems.   
 
Figure 3.8– Screen capture of the Protein table view of the DeCyder 2D gel analysis software. 
(Refer to text for details) 
 
The system under analysis compares the wild type B. subtilis strain 168 to the yflMd 
bNOS knockout strain.  Since the downstream elements in the knockout strain were placed 
under the control of an IPTG-inducible promoter, IPTG was added to make the system a one 
gene knockout.  To account for the change within the system due to IPTG induction, 4 
systems were compared in the DIGE analysis: (i) knockout, (ii) wild type, (iii) knockout with 
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IPTG, and (iv) wild type with IPTG.  Triplicates of each system and a pooled internal 
standard were run together in a 6 gel DIGE experiment.  A minimum of 6 gels are required in 
this system for determination of statistical significance of the change in protein expression 
between the 4 systems.  Data analysis compared the change in expression between the 
knockout and the wild type, with and without IPTG, independently.  Statistical analysis 1 
compared the wild type and the knockout systems both without IPTG, showing the effects 
due to the knockout of the promoter of the gene of interest.  Statistical analysis 2 compared 
the wild type system and the knockout system with IPTG, showing the effects due to the 
knockout of the gene of interest plus any effects due to the presence of IPTG.  A comparison 
between these two sets of data allows for the exclusion of the changes due to the downstream 
element.   
The proteins that changed significantly between the two systems were determined to 
be due solely to the effects of the gene of interest.  Figure 3.9 shows a visual representation 
of the data obtained from one gel, comparing the wild type and the knockout system.  
Proteins that are up-regulated in the knockout are shown in green, proteins that are down-






Figure 3.9– Tricolour comparison of the change in protein expression due to bNOS knockout in Bacillus 
subtilis.   
Proteins that are coloured red are down-regulated in the knockout.  Proteins that are coloured green are up-
regulated in the knockout.  The expression of those proteins that are coloured yellowish/white do not change 
between the two systems.  The Differential in Gel Electrophoresis analysis was performed on bacterial cultures 
harvested at the end of log phase.  B. subtilis 168 sample, 150 μg of total protein separated on pH 4-7 IPG and 
12.5 % SDS PAGE.  Samples, pooled internal standard, yflMd and wild type, were labeled with 200 pmol of 
Cy2, Cy3 and Cy5, respectively.  
3.3.4 Protein Identification 
Proteins can be identified using two different techniques: via PMF or via MS/MS ion 
search.  Both methods rely on the trypsin digestion of a protein spot picked from a gel but 
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use different methods for determination of protein identity.  The trypsin digestion 
fractionates the protein in a characteristic pattern known as a PMF.  PMF identification is 
based off a discrete section of the MS spectra of the trypsin digested sample searched against 
databases that have been generated for known proteins.  This method can use MALDI MS 
which is less sensitive to contaminants, more sensitive for protein detection and amenable to 
a high through-put work-flow.  MS/MS ion searching relies on the generation of MS/MS data 
for the digested peptides.  It is the MS/MS of these peptides that is used in the database 
search to determine the protein identity.  The MS/MS of the peptide essentially allows for the 
sequencing of the peptide by comparison of the mass difference in the fragmentation to the 
mass of individual amino acid residues.  This method is invaluable to identify proteins from 
organisms whose genomes have not been sequenced, as a BLAST search can be performed to 
the peptide sequence to find homologues and tentatively assign function to these proteins.  
This technique is however significantly more time consuming, more expensive and more 
sensitive to contaminants.   
The current statistical requirements for significance, p ≤ 0.05 and a │fold change│ ≥ 
2, yield a pick list of 73 proteins shown in Appendix A Table 1.  Of these 73 proteins 16 
proteins have been identified, among which 2 were identical.  Table 3.3 shows the results of 









coveagec BSORFIDd Protein Identity Pathwaye 
            
no -4.0 34 dhaS Aldehyde dehydrogenase Glycolysis / Gluconeogenesis 
        Ascorbate and aldarate metabolism 
        Fatty acid metabolism 
        Bile acid biosynthesis 
        Valine, leucine and isoleucine degradation 
        Lysine degradation 
        Arginine and proline metabolism 
        Histidine metabolism 
        Tryptophan metabolism 
        beta-Alanine metabolism 
        Glycerolipid metabolism 
        Pyruvate metabolism 
        Propanoate metabolism 
        Butanoate metabolism 
          Limonene and pinene degradation 
no -13.2 34 acoB acetoin dehydrogenase E1 component Glycolysis / Gluconeogenesis 
       (TPP-dependent beta subunit) Valine, leucine and isoleucine biosynthesis 
        Pyruvate metabolism 
          Butanoate metabolism 
no -16.4 47 citH Malate dehydrogenase Citrate cycle (TCA cycle) 
        Pyruvate metabolism 
        Glyoxylate and dicarboxylate metabolism 
        Carbon fixation 
          Reductive carboxylate cycle (CO2 fixation) 
      
no -8.4 56 sdhA succinate dehydrogenase flavoprotein subunit Citrate cycle (TCA cycle) 
        Oxidative phosphorylation 
        Benzoate degradation via CoA ligation 
        Butanoate metabolism 
          Reductive carboxylate cycle (CO2 fixation) 
no -2.8 51 etfB Electron transfer flavoprotein beta subunit 










coverage BSORFID Identification Pathway 
            
no -2.1 35 ArgC N-acetyl-glutamate-gamma-semialdehyde dehydrogenase Urea cycle and metabolism of amino groups 
no -5.7 6 carB Carbamoyl-phosphate synthase large chain Pyrimidine metabolism 
        carbamoyl-phosphate transferase-arginine (subunit B) Glutamate metabolism 
      
no 2.5 61 rocG Glutamate Dehydrogenase Glutamate metabolism 
          Nitrogen metabolism 
      
no 2.2 53 serA Phosphoglycerate dehydrogenase Glycine, serine and threonine metabolism 
      
no 2.6 39 AroA 3-deoxy-7-phosphoheptulonate synthase 
Phenylalanine, tyrosine and tryptophan 
biosynthesis 
no -10.8 22 hutU urocanate hydratase Histidine metabolism 
           
no -5.2 38 HutG Formimino glutamase Histidine metabolism 
      
no 3.3 25 mtnK methylthioribose kinase Metabolism of amino acids and related  
         molecules 
no 15.3 26 mtnS Translational initiation factor eIF-2B alpha chain homolog Metabolism of amino acids and related molecules 
      
yes -6.2 138 nusA transcription termination factor Transcription elongation protein nusA. 
aA systematic study generating knockouts to every gene in the B. subtilis genome has been used to determine the requirement for specific proteins for cell 
viability.  This information can be accessed at http://bacillus.genome.jp/  
bFold change - the relative abundance change of the proteins spots from a comparison of wild type vs. knockout.  Fold changes less than 1 are represented as the 
negative inverse ratio. 
cPercentage of amino acid sequenced used to identify the protein by mass spectrometry. 
dBSORFID – gene name as given on http://bacillus.genome.jp/ 
ePathways identified given by KEGG that utilize the protein identified by mass spectrometry 
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We can be confident that those changes exhibited in the knockout system are not due 
to polar affects because the closest locus that has been identified to be affected is more than 
42 kbp downstream.  Not only are there more than 10 terminator sequences between these 
two loci, but none of the other genes located between these loci have been identified to be 
influences by the knockout.  Thus the changes identified in this system are not due to polar 
effects introduced by the integration of the knockout vector into the chromosomal DNA. 
Two protein spots that were determined to change significantly due to the bNOS 
knockout were identified to be aldehyde dehydrogenase when analyzed by MS.  Both protein 
spots were down regulated in the knockout by 4.0 and 3.7 fold, respectively.  These proteins 
pictured in Figure 3.10, appear to have the same MW but distinct pI values, as illustrated by 
the differential migration in the horizontal direction.  Raggiaschi et al. in 2006 used a 2D-
DIGE system to look at the migrational due to phosphorylation of protein samples.  They 
determined phosphorylation patterns in rat cortical neurons by analysis of a normal and 
phosphatase treated sample.  They showed 2D-DIGE to be a useful tool for identifying PTM 
via a shift in pI values.  Further studies using Western Blot analysis are required to confirm 




Figure 3.10– Comparison of two protein spots which resulted in the same MS identification.    
The molecular weight of the two proteins appears to be maintained while there is a distinct shift in the pIs, 
illustrated by the horizontal shift in migration pattern.   
 
The identification of more proteins on this pick list will continue.  The challenge of 
identifying these proteins has been primarily due to their low abundance.  In order to identify 
more proteins from the pick list shown in Table 1 in Appendix A, protein spots from multiple 
gels will need to be pooled to have enough protein to identify the spot by mass spectrometry.  
Furthermore, although the parameters used for statistical significance are relatively normal, 
many proteomics studies pick a lower cut-off for significance of fold change.  Lowering the 
change cut-off to 50% (fold change of 1.5) could allow the inclusion of proteins with higher 
abundance that would have a more significant impact on the cell, shown in Appendix A 
Table 2.  This cut-off is still significantly higher than that suggested by the manufacturer, GE 
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Healthcare, as they claim their product is capable of quantitatively determining a 10 % 
change between two systems with greater than 95 % statistical confidence. 
3.4 Discussion 
3.4.1 2D Electrophoresis 
Proteomic analysis using 2D gel electrophoresis requires reproducibly distinct 
separation of proteins within a sample.  It is ideal to keep sample preparation to a minimum 
for reproducibility reasons but it cannot be stressed enough that every step in sample 
preparation is critical.  
2D gel electrophoresis is often plagued with streaking problems.  Procedures are 
often unique to the sample being run and require sample specific trouble shooting.  Streaking 
issues are particularly evident in samples obtained from microorganisms with complex cell 
walls (Herbert, Grinyer et al., 2006).  There are two types of streaking in 2D gels, horizontal 
and vertical streaking, both with unique causes and solutions.  An example of both horizontal 




Figure 3.11– 2D gel of B. subtilis pH 4-7 demonstrating both horizontal and vertical streaking. 
B. subtilis 168 sample, 200 μg of total protein separated on pH 4-7 IPG and 10 % SDS PAGE.  Gel stained with 
Deep Purple total protein stain.   
 
Horizontal streaking has two primary causes: (i) increased conductivity of the sample 
and (ii) precipitation of proteins during IEF.  Increased conductivity in the sample can result 
from the presence of salts, polysaccharides, nucleic acids and macromolecules (Vandahl, 
Christiansen et al., 2002).  The presence of salts is perhaps the most common cause of 
horizontal streaking.  Salts can be removed by washing the cells prior to lysis, precipitation 
of the sample, and by switching of the paper wicks during prolonged IEF times (Gorg, 
Obermaier et al., 2000).  Polysaccharides and nucleic acids can interact with the carrier 
ampholytes and the proteins, interfering with IEF conditions.  These contaminants can be 
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removed by precipitation and nuclease treatment of the samples.  Macromolecules can 
actually increase the viscosity of the solution to such an extent that the pores in the IEF gel 
can be obstructed (Gorg, Weiss et al., 2004).  Macromolecules can be removed from the 
sample by ultracentrifugation or by using protein extraction methods that do not solubilize 
these contaminants (Herbert, Grinyer et al., 2006).  
The other main cause of horizontal streaking is poor solubilization of the sample.  
Poor solubilization of protein can be a result of high protein loads and differing detergent 
requirements for specific samples.  Increased protein loads are particularly desirable for 
preparative gels when excising protein spots for identification by MS.  Samples are often 
hard to resuspend after precipitation and are at their limit of solubility.  Thus proteins often 
precipitate out of solution during sample loading.  To rectify this problem, gel strips can be 
rehydrated with rehydration buffer and samples can be loaded with a low current (Sabounchi-
Schutt, Astrom et al., 2000).  Alternatively, protein fractionation allows for the splitting of 
different proteins into different samples prior to sample application (Lilley, Razzaq et al., 
2001).  Fractionation allows for an increased amount of total protein to be loaded, which is 
distributed over multiple gels.  Another cause of poor solubility of the sample could be a 
result of the inadequacy of the detergent.  Currently CHAPS is the most commonly used 
detergent due to background smearing associated with detergents such as Triton X-100 and 
Nonidet P-40 (Gorg, Obermaier et al., 2000).  However, some samples, particularly those 
with high amounts of lipids, may have different detergent requirements.  There are many 
alternative detergents, the only requirement is that the detergent be zwitterionic or nonionic 
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so it does not interfere with IEF.  Which detergent is best for a given sample can still not be 
predicted (Vandahl, Christiansen et al., 2002).   
Horizontal streaking can also result from depletion of reducing agent or 
carbamylation within the protein sample.  Reducing agents such as DTT or DTE are essential 
to disruption of disulfide bonds.  Since the pka of DTT and DTE are 8.5 and 9, respectively, 
streaking can result due to depletion of reducing agent at the basic end of the IEF strip (Gorg, 
Weiss et al., 2004).  This can be rectified by either placing DTT soaked paper wicks at the 
cathodic end of the IEF gel, to provide a constant in flux of reducing agent, or by stabilizing 
the disulfides as mixed disulfides using hydroxyethyl-disulfide (HED) reagent (Gorg, Weiss 
et al., 2004) (Destreak, GE Healthcare).  Carbamylation results from the interaction of 
isocyanate, a degradative product of urea, and primary amines and can affect the migration of 
proteins during IEF (Gorg, Weiss et al., 2004).  Protein carbamylation can be avoided by 
ensure the sample is never heated above 37ºC. 
  One final cause of horizontal streaking results from an inadequate IEF program.  
Protocols suggest a range of 35-120 kVhr for IEF programs (Sabounchi-Schutt, Astrom et 
al., 2000).  The real challenge arises in determination of an adequate IEF program due to the 
fact that overfocusing and underfocusing both result in streaking (Gorg, Obermaier et al., 
2000).  Thus trouble shooting this parameter can be frustrating and time consuming.   
Vertical streaking is normally caused by inefficient transfer of protein from the IEF 
strip to the SDS gel.  There are several causes of this phenomenon.  This could be caused by 
poor equilibration in the SDS equilibration buffer.  Making up fresh buffer and increasing 
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equilibration time may rectify this problem.  A poor transfer of protein into the 2D dimension 
may also be solved by decreasing the voltage during the transfer (the first hour of 
electrophoresis in the second dimension).  The most common cause of streaking in the 
vertical direction is caused by depletion of SDS in the upper buffer chamber.  This could be 
caused by leaking in the upper buffer chamber.  It is recommended that the seals are checked 
and that fresh buffers are made.  
3.4.2 Perspectives on the Role of NOS in Bacteria 
A broader scope is required before definitively outlining the role of NOS in bacterial 
systems.  Until more proteins can be identified we can use the proteins that have been 
identified to speculate on a plausible role.   
The proteins identified thus far can be grouped into three categories: (i) glucose 
metabolism, (ii) amino acid metabolism, (iii) nitrogen metabolism, and (iv) transcriptional 
factors.   
3.4.2.1 Glucose Metabolism and Alternative Carbon Source Utilization 
Several of the proteins identified thus far suggest a down-regulation of glucose 
metabolism in the knockout.  This is exhibited by the down-regulation of enzymes involved 
in glycolysis, the TCA cycle, and membrane bioenergetics.  This down regulation of glucose 
metabolism is exhibited in Figure 3.12.  Two enzymes are believed to show the down-
regulation of glycolysis: (i) aldehyde dehydrogenase (dhaS) and (ii) phosphoglycerate 
dehydrogenase (serA).  dhaS is involved in the conversion of pyruvate to acetyl-CoA 
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(Kanehisa, Goto et al., 2006) is down-regulated 4.0 fold in the yflMd strain.  Whereas, serA 
is involved in the conversion of 3-P-Glycerate to serine (Kanehisa, Goto et al., 2006).  This 
enzyme is up-regulated in the yflMd strain showing the alternate usage of this glycolytic 
intermediate for amino acid biosynthesis.   
The down-regulation of the TCA cycle is shown in the repression of malate 
dehydrogenase (citH) and succinate dehydrogenase (sdhA) by 16.4 and 8.4 fold, respectively.  
These two proteins catalyze the conversion of malate to oxaloacetate (Jin, De Jesus-Berrios 
et al., 1996) and succinate to fumarate (Melin, Magnusson et al., 1987) in the TCA cycle.  
Glutamate dehydrogenase (rocG) catalyzes the conversion of 2-oxoglutarate to glutamate 
(Belitsky and Sonenshein, 1998).  This process is up-regulated in the yflMd strain showing 
the alternate usage of TCA cycle intermediates. 
The repression of proteins involved in the electron transport chain is exhibited in the 
down-regulation of the electron transfer flavoprotein (etfB) and as well as sdhA by 2.8 and 
8.4 fold, respectively.  Both these enzymes are involved in oxidative phosphorylation 
(Kanehisa, Goto et al., 2006).  sdhA interacts directly with ubiquinone donating electrons 
into the electron transport chain.  etfB accepts electron from other dehydrogenases and 
transfers them to the respiratory chain via ETF-ubiquinone oxidoreductase.   
 It is interesting to note that the down-regulation of alternative carbon source 
utilization is also evident in the knockout strain.  This is exhibited by the down-regulation of 


































































Figure 3.12 – Summary of metabolic pathways affected by the yflMd knockout. 




One interesting aspect of the change in protein expression between these two systems 
is the down regulation of glucose metabolism and alternative carbon source utilization.  
Samples were taken at the end of the cultures growth cycle at which point glucose is depleted 
in the media and the culture generally shifts to using alternative carbons sources, such as 
acetoine (Butt, Bernhardt et al., 2000).  Both glucose and acetoine utilization appear to be 
down-regulated.   
Since the yflMd strain appears to affect similar genes as those in glucose starvation 
but with differing effects, it appears that the yflM gene may somehow work to modulate the 
glucose starvation response.     
3.4.2.2 Amino Acid Metabolism 
Amino acid metabolism is also significantly repressed in the yflMd strain.  The yflMd 
strain exhibits both a down-regulation of amino acid catabolism and an up-regulation of 
amino acid biosynthesis is exhibited in Figure 3.12.  The down-regulation of histidine 
catabolism (Kimhi and Magasanik, 1970) is shown by the repression of both urocanate 
hydratase (hutU) and formimino glutamase (hutG) by 10.8 and 5.2 fold, respectively.   
The up-regulation of amino acid biosynthesis is shown by the induction of chorismate mutase 
(aroA), methylthioribose kinase (mtnK), and serA by 2.6, 3.3, and 2.2, fold respectively.  
These enzymes contribute to pathways that are involved in biosynthesis of Phe, Tyr, Trp, 
Met, Gly, Ser, and Thr (Sekowska, Mulard et al., 2001; Kanehisa, Goto et al., 2006).   
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The up-regulation of rocG may also contribute to amino acid biosynthesis as the product 
glutamate is the main amino donor for transamination reactions. 
The significance of up-regulation of amino acid biosynthesis is unknown, however 
the glucose starvation response also showed a repression of catabolic pathways (Butt, 
Bernhardt et al., 2000).  This may indicate that yflM is involved in regulation of the glucose 
starvation response or in the regulation of the synthesis of specific amino acids required for 
an adaptive response to the lack of •NO in the knockout. 
3.4.2.3 Nitrogen Metabolism 
Nitrogen metabolism is also significantly affected in the yflMd strain. The down-
regulation of nitrogen metabolism is shown in the repression of N-acetyl-glutamate-
semialdehyde dehydrogenase (argC) and Carbamoyl-phosphate synthase (carB) by 2.1 and 
5.7 fold, respectively (Kanehisa, Goto et al., 2006).  These enzymes are involved in reactions 
that feed into the urea cycle.  Interestingly, these reactions are allosterically inhibited by L-
Arg.  If the physiological substrate for bNOS is actually L-Arg, a build-up of L-Arg in the 
knockout would result in the repression of this process.   
This study shows that the expression of the yflM gene significantly affects nitrogen 
metabolism.  The yflMd knockout results in the down-regulation of the urea cycle and amino 
acid catabolism and the up-regulation of amino acid biosynthesis.  As mentioned in section 
3.3.1.2, there are other contributing factors to nitrogen metabolism, however, the use of a 
comparative system should keep these factors consistent between the wild type and the 
knockout.   
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Perhaps the down-regulation of nitrogen metabolism is a result of the decreased 
production of •NO and nitrogen containing metabolic intermediates fueled into the urea cycle 
for bioprocessing.  Alternatively the up-regulation of amino acid biosynthesis in the 
knockout could be a result of the absence of •NO as a regulative factor.  The apparent up-
regulation of amino acid biosynthesis relative to the wild type, could be a result of the down-
regulation of amino acid biosynthesis in the wild type.  This would be a reasonable 
assumption since the down-regulation of protein synthesis has been observed in cells at the 
end of log phase in a proteomic study by Bernhardt et al. in 2006. 
3.4.2.4 Transcriptional Factors 
Two of the proteins identified thus far are transcriptional factors.  nusA is a general 
transcriptional termination factor (Ingham, Dennis et al., 1999), which has been shown to be 
essential in B. subtilis (Ingham, Dennis et al., 1999).  nusA is down-regulated in the yflMd 
strain.  mtnS is a transcriptional factor that is part of the S box Regulon which controls sulfur 
metabolism and biosynthesis of Cys and Met (Grundy and Henkin, 1998).  mtnS is up-
regulated in the knockout strain and may thus further contribute to the up-regulation of amino 
acid biosynthesis.   
The down-regulation of the transcriptional factor nusA could add weight to the 
potential role of •NO as a regulative factor.  The apparent down-regulation of this general 
transcriptional terminator in the knockout relative to the wild type could be a result of the up-
regulation of this transcriptional factor in the wild type.  This could result in increased 




3.4.2.5 Quorum-Sensing Precursor Generation 
Another interesting difference between the two systems is seen in the induction of 
two genes from the S box regulon, mtnS and mtnK.  These genes are implicated in the 
recycling of methylthioribose (MTR), a precursor for quorum-sensing molecules (Sekowska, 
Mulard et al., 2001).  Again these genes are normally induced under glucose starvation but 
are induced to an even greater extent in the yflMd strain.  It appears that yflM may regulate 
the cell’s response to glucose starvation.  B. subtilis uses a LuxS quorum-sensing signaling 
molecule to regulate spore morphogenesis, biofilm formation, and swarming.  MTR is fed 
into the pathway producing LuxS (Singh, Shi et al., 2006).  Quorum-sensing acts in a cell 
density dependent manner and would be found at high cell densities like those found at the 
end of the log phase.  Perhaps this apparent up-regulation of quorum-sensing in the knockout 
relative to the wild type could be a result of the down-regulation in the wild type.  Again 
these effects could be a result of the yflM gene or its product ·NO contributing to a regulative 
mechanism at the end of log phase.  Although the use of ·NO donors would allow the 
distinction between these two effects, the reintroduction of ·NO in this unregulated manner 
would be more appropriate to a phenotypic analysis.    
 
Exactly how these interactions occur is still unknown.  These studies do not allow us 
to differentiate between whether the bsNOS gene or its ·NO product is the influencing factor.  
Neither do they allow for the differentiation between whether the change in expression is due 
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to a change in de novo protein synthesis or protein degradation.  Future studies are required 
to determine the specifics of these interactions. 
3.5 Future Directions 
Although the present analysis has shed some light on the role of NOS in bacterial 
systems, the identification of more proteins is required for a better understanding.  The 
identification of more proteins requires the pooling of protein spots of low abundance 
proteins from multiple gels and the picking of spots of higher abundance whose relative 
change may be less but whose change in expression would have a more significant impact on 
the cell.  The identification of more proteins will either confirm or disprove hypotheses 
presented in this paper.   
This study was conducted at the point in the growth curve that showed the highest 
expression of the bsNOS gene as determined by β-Gal expression tests.  Since it has been 
suggested that the role of this gene may partially be regulative, it would be interesting to 
compare the change in protein expression between these two systems during different stages 
of growth.  Similar methods have been used with B. subtilis and S. aureus to determine the 
change in protein expression due to the sigB regulon (Butt, Bernhardt et al., 2000) and the 
hemB gene (Kohler, von Eiff et al., 2003), respectively.   
In conjunction with the proteomic study at different stages of growth, it would be 
beneficial to look at the change in translation due to this genetic knockout.  The changes in 
translational activity more accurately shows regulation as it focuses on those proteins that are 
being actively expressed.  Studies using L-[35S]methionine incorporation would be used to 
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monitor translation of proteins.  Samples would be analyzed using the 2D gel methods 
outlined in this thesis to separate proteins.  Visualization of gels would be preformed using 
autoradiography and is compatible with DeCyder software used for the current study.  
Previous work used similar methods to monitor the change in the translation, in response to 
environmental stress (Mostertz, Scharf et al., 2004).   
3.5.1 •NO-mediated Posttranslational Modification 
Another extension of this project would be to look at the change in •NO-mediated 
PTM within the two systems.  Since the bNOS enzyme is suspected to produce •NO it has 
been suggested that it may play a role in •NO-mediated PTM.  There are four possible kinds 
of •NO-mediated PTMs: (i) binding to metal centers, (ii) nitrosylation of thiol and amine 
groups, (iii) nitration of tyrosine, tryptophan, amine, carboxylic acid, and phenylalanine 
groups, and (iv) oxidation of thiols and tyrosine (Green, Wagner et al., 1982).  The 
significance of a change in PTM within a proteome is becoming increasingly evident with the 
analysis of the proteomes of cells in diseased states.  Thus the change in protein nitration and 
nitrosylation will also be investigated using a similar system to the DIGE analysis.   
Several mechanisms have been previously used to explore the PTM within proteomes.  Most 
PTM work has been done on phosphorylation and methylation and the principles from these 
studies will be used to design the current system (Raggiaschi, Lorenzetto et al., 2006).  PTM 
analysis can be accomplished using two different approaches: immunoprecipitation/Biotin-
switch method or Western Blot analysis.   
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The immunoprecipitation or Biotin-switch method allows removal of •NO-mediated 
PTM proteins from the system.  The change in the S-nitrosyl/nitrotyrosyl-proteome can then 
be assessed either by looking at the absence of these proteins in the overall proteome or in 
the appearance of proteins in the isolated fraction.  The S-nitroso proteome of 
Mycobacterium tuberculosis was analyzed using the Biotin-switch method (Rhee, 
Erdjument-Bromage et al., 2005).  This method selectively replaces the NO moieties of 
target cyteine nitrosothiols with a disulfide linkage to a biotin derivative allowing the 
isolation of these proteins by streptavidin affinity chromatography.  These methods produced 
29 S-nitroso proteins that were separated by 1D gel electrophoresis and identified by MS.  To 
get an overall picture of the •NO-mediated PTM proteome both the S-nitroso and 
Nitrotyrosyl-proteomes would be isolated.  Coupling the biotin-switch methods with 
immunoprecipitation method followed by electrophoresis would allow for analysis of the 
NO-mediated PTM of the proteome.  Difficulties in this method could result from loss of 
proteins during processing.  Conditions needed for maximal solubility within the proteome 
may also not be able to be maintained during biotin-switch and immunoprecipitation 
procedures, resulting in an incomplete view of the proteome.    
Another method used, and perhaps the most obvious one, for PTM analysis is 
Western Blot analysis of 2D gels.  This may seem like the simplest method however, this 
would be least reproducible method.  Differences due to gel to gel variability combined with 
variations introduced during the transfer process will amplify any differences between runs.  
Antibodies to nitrotyrosine have been used to analyze the distribution of tyrosine nitration in 
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rat tissue extracts (Aulak, Miyagi et al., 2001) and human pituitary tissue extracts (Zhan and 
Desiderio, 2004).  These methods produced 40 and 16 nitrotyrosine-immunoreactive 
proteins, respectively.  The Biotin-switch method can be adapted for immunoblotting 
purposes and thus the •NO-mediated PTM proteome can be analyzed on the same membrane.  
Comparison of two systems may lead to difficulties due to gel to gel variability, however 
reproducible 2D-Western analysis could be accomplished using a fluorescently labeled 2º 
antibody and the DeCyder software, analogous to the 2D-DIGE analysis.  Further analysis of 
the change in protein expression over time between the two systems would not only shed 
light on the role of bNOS enzymes but could also add to the evidence that •NO-mediated 






Table 1 -  Pick list for proteins p ≤ 0.05 and │fold change│ ≥2 
  WT vs KOc  WTvsKOIPTGd  





1 69 18 (18)  A, M 0.0017 -3.95 0.0019 -4.91 
2 87 18 (18)  A, M 0.0098 -2.63 0.003 -2.86 
3 272 18 (18)  A, M 0.022 -2.31 0.0022 -3.32 
4 281 18 (18)  A, M 0.0027 -2.11 0.00083 -2.12 
5 473 18 (18)  A, M 0.0086 -3.74 0.0005 -3.89 
6 509 18 (18)  A, M 0.0077 -2.21 0.00094 -2.7 
7 522 18 (18)  A, M 0.014 -2.05 0.00097 -2.5 
8 532 18 (18)  A, M 4.90E-06 -2.43 0.0076 -2.48 
9 575 18 (18)  A, M 0.016 -5.99 0.0024 -10.84 
10 581 18 (18)  A, M 0.034 -4.38 0.00054 -8.4 
11 586 18 (18)  A, M 0.018 -3.72 0.0012 -6.6 
12 590 18 (18)  A, M 0.027 -2.87 0.0072 -3.51 
13 595 18 (18)  A, M 0.0091 -2.7 0.011 -5.32 
14 664 18 (18)  A, M 0.00023 2.41 0.0065 2.21 
15 667 18 (18)  A, M 0.0005 2.5 0.0038 2.25 
16 771 18 (18)  A, M 0.039 -3.06 0.0093 -3.98 
17 772 15 (18)  A, M 0.027 -2.88 0.037 -3.72 
18 924 18 (18)  A, M 0.0058 -2.45 0.0053 -2.26 
19 985 12 (18)  A, M 0.0071 -3.01 0.006 -3.65 
20 1011 18 (18)  A, M 0.038 -2.24 0.0031 -3.14 
21 1047 18 (18)  A, M 0.0006 8.05 0.00028 9.48 
22 1058 18 (18)  A, M 0.05 2.12 0.037 2.51 
23 1062 18 (18)  A, M 0.025 2.73 0.0037 3.39 
24 1070 18 (18)  A, M 0.014 -3.17 0.0045 -3.57 
25 1137 18 (18)  A, M 0.042 5.2 0.049 4.68 
26 1148 18 (18)  A, M 0.023 2.52 0.00059 3.29 
27 1175 18 (18)  A, M 0.0049 -4.99 0.0022 -6.17 
28 1239 15 (18)  A, M 7.00E-05 25.68 4.50E-05 31.99 
29 1309 18 (18)  A, M 1.10E-05 12.62 8.80E-06 15.31 
30 1310 15 (18)  A, M 0.028 2.74 0.04 2.72 
31 1337 15 (18)  A, M 0.015 2.46 0.0041 2.7 
32 1339 15 (18)  A, M 0.03 -2.64 0.045 -2 
33 1343 15 (18)  A, M 0.045 -6.26 0.00099 -10.45 
34 1357 18 (18)  A, M 0.0097 2.5 0.00034 2.57 
35 1358 15 (18)  A, M 0.041 3.58 0.02 3.43 
36 1361 18 (18)  A, M 0.00026 7.65 8.70E-06 7.57 
37 1410 18 (18)  A, M 0.00096 4.87 0.002 3.81 
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38 1412 18 (18)  A, M 0.0027 -3.56 0.038 -2.09 
39 1417 15 (18)  A, M 0.0013 3.53 0.0014 3.67 
40 1441 15 (18)  A, M 0.023 -3.08 0.0045 -4.05 
41 1458 12 (18)  A, M 0.00037 3.69 0.00092 3.27 
42 1467 18 (18)  A, M 0.046 -3.58 0.024 -4.15 
43 1526 18 (18)  A, M 0.024 -5.33 0.0032 -8.39 
44 1531 15 (18)  A, M 0.042 -3.3 0.0075 -4.18 
45 1573 18 (18)  A, M 0.0059 -3.9 0.0028 -5.22 
46 1581 18 (18)  A, M 0.04 -2.33 0.00081 -2.34 
47 1586 18 (18)  A, M 0.037 -2.35 0.011 -2.84 
48 1601 15 (18)  A, M 0.012 -2.05 0.041 -2.14 
49 1765 15 (18)  A, M 0.034 -7.86 0.0067 -11.39 
50 1808 15 (18)  A, M 0.0055 -2.94 0.022 -2.88 
51 1815 18 (18)  A, M 0.024 -2.58 0.0058 -2.47 
52 1852 15 (18)  A, M 0.014 -2.63 0.0037 -3.29 
53 1869 18 (18)  A, M 0.037 -2.18 0.003 -2.46 
54 1875 18 (18)  A, M 0.019 3.57 0.022 3.42 
55 1941 18 (18)  A, M 0.00041 2.79 0.00033 2.65 
56 1989 18 (18)  A, M 0.027 2.46 0.047 2.15 
57 1995 15 (18)  A, M 0.027 3.19 0.02 3.81 
58 2017 15 (18)  A, M 0.0063 -6.28 0.0073 -5.64 
59 2050 18 (18)  A, M 0.02 2.4 0.01 2.25 
60 2112 15 (18)  A, M 0.0044 -5.5 0.0018 -6.08 
61 2114 18 (18)  A, M 0.02 3.08 0.0063 2.6 
62 2206 18 (18)  A, M 0.011 -2.54 0.0078 -2.7 
63 2277 15 (18)  A, M 0.019 -2.24 0.014 -2.63 
64 2316 15 (18)  A, M 0.04 -2.96 0.003 -3.55 
65 2349 18 (18)  A, M 0.004 -3.04 0.0085 -2.46 
66 2356 18 (18)  A, M 0.041 -3.56 0.0059 -3.92 
67 2432 15 (18)  A, M 0.0035 -3.92 0.0026 -5.08 
68 2532 15 (18)  A, M 0.041 -2.62 0.013 -2.74 
69 2555 18 (18)  A, M 0.047 -2.33 0.0026 -3.24 
70 2575 18 (18)  A, M 0.011 -6.26 0.0036 -6.41 
71 2589 18 (18)  A, M 0.0089 -2.21 0.022 -2.14 
72 2601 18 (18)  A, M 0.05 2.52 0.04 2.62 
73 2643 12 (18)  A, M 0.017 -4.8 0.047 -3.23 
aMaster No. – based on protein number assigned in DeCyder software 
bAppearance shows the number of gels that contain the specific protein spot 
cWT vs KO – Statistical analysis comparing wild type to knockout 
dWT vs KOIPTG - Statistical analysis comparing wild type to knockout with IPTG 
e Fold change - the relative abundance change of the proteins spots from a comparison of wild type vs. 





Table 2 -  Pick list for proteins p ≤ 0.01 and │fold change│ ≥1.5 
 WT vs KOc  WT vs KOIPTGd  





1 69 18 (18)  A, M 0.0017 -3.95 0.0019 -4.91 
2 87 18 (18)  A, M 0.0098 -2.63 0.003 -2.86 
3 281 18 (18)  A, M 0.0027 -2.11 0.00083 -2.12 
4 473 18 (18)  A, M 0.0086 -3.74 0.0005 -3.89 
5 509 18 (18)  A, M 0.0077 -2.21 0.00094 -2.7 
6 532 18 (18)  A, M 4.90E-06 -2.43 0.0076 -2.48 
7 656 18 (18)  A, M 0.00024 2.17 0.004 1.87 
8 664 18 (18)  A, M 0.00023 2.41 0.0065 2.21 
9 667 18 (18)  A, M 0.0005 2.5 0.0038 2.25 
10 779 18 (18)  A, M 0.00082 1.77 0.0015 1.97 
11 807 18 (18)  A, M 0.0086 1.84 0.0036 1.86 
12 924 18 (18)  A, M 0.0058 -2.45 0.0053 -2.26 
13 947 18 (18)  A, M 0.00074 1.73 0.0076 1.59 
14 985 18 (18)  A, M 0.0071 -3.01 0.006 -3.65 
15 1047 18 (18)  A, M 0.0006 8.05 0.00028 9.48 
16 1066 18 (18)  A, M 0.0074 1.66 0.0032 1.58 
17 1151 18 (18)  A, M 0.009 1.89 0.00083 2.09 
18 1157 18 (18)  A, M 0.0024 1.89 0.00062 2.05 
19 1175 18 (18)  A, M 0.0049 -4.99 0.0022 -6.17 
20 1239 15 (18)  A, M 7.00E-05 25.68 4.50E-05 31.99 
21 1309 18 (18)  A, M 1.10E-05 12.62 8.80E-06 15.31 
22 1357 18 (18)  A, M 0.0097 2.5 0.00034 2.57 
23 1361 18 (18)  A, M 0.00026 7.65 8.70E-06 7.57 
24 1410 18 (18)  A, M 0.00096 4.87 0.002 3.81 
25 1417 15 (18)  A, M 0.0013 3.53 0.0014 3.67 
26 1422 18 (18)  A, M 0.0078 1.71 0.0052 1.79 
27 1573 18 (18)  A, M 0.0059 -3.9 0.0028 -5.22 
28 1627 18 (18)  A, M 0.00072 1.67 0.0017 1.68 
29 1878 18 (18)  A, M 0.003 1.96 0.0011 2.25 
30 1941 18 (18)  A, M 0.00041 2.79 0.00033 2.65 
31 2017 15 (18)  A, M 0.0063 -6.28 0.0073 -5.64 
32 2054 18 (18)  A, M 0.00057 1.79 0.00029 1.75 
33 2057 18 (18)  A, M 0.0027 1.52 0.0042 1.72 
34 2060 18 (18)  A, M 0.00024 2.52 0.0013 1.92 
35 2112 15 (18)  A, M 0.0044 -5.5 0.0018 -6.08 
36 2334 18 (18)  A, M 0.0064 1.54 0.00012 1.57 
37 2349 18 (18)  A, M 0.004 -3.04 0.0085 -2.46 
38 2417 18 (18)  A, M 0.0046 1.9 0.0016 1.84 
39 2432 15 (18)  A, M 0.0035 -3.92 0.0026 -5.08 
40 2613 18 (18)  A, M 0.0035 1.68 0.0044 1.61 
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